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ABSTRACT 
 
Phosphonates are a class of organophosphorus compounds with a characteristic 
carbon–phosphorus bond.  The carbon–phosphorus lyase complex, encoded by the 
genes phnGHIJKLM, catalyzes the cleavage of the stable carbon–phosphorus bond of 
organophosphonates to the corresponding hydrocarbon and inorganic phosphate. 
Recently, complexes of this enzyme containing five subunits (PhnG-H-I-J-K), four 
subunits (PhnG-H-I-J), and two subunits (PhnG-I) were purified after expression 
in Escherichia coli.  
Here we used mass spectrometry, ultracentrifugation, chemical cross-linking, N-
terminal protein sequencing and single-particle cryo-electron microscopy experiments, 
revealing subunits interactions and construct structural models for the PhnG2H2I2J2 and 
PhnG2H2I2J2K C–P lyase complexes from E. coli.  The proposed stoichiometry, subunit 
interaction and structural model of PhnG2H2I2J2 complex agreed quite well with the 
crystal structure that was published later.  PhnG2H2I2J2 is a two-fold symmetric hetero-
octamer. Its two PhnJ subunits provide two identical binding sites for PhnK.  Only one 
PhnK binds to PhnG2H2I2J2 due to steric hindrance. Moreover, binding of PhnK exposes 
the active site residue, Gly32 of PhnJ, located near the interface between PhnJ and 
PhnH.  This structural information provides a basis for further deciphering of the 
reaction mechanism of the C-P lyase.  
A group of organophosphorus compounds, the phosphotriester plasticizers and 
flame retardants, has recently become widely used.  This group of compounds lacks an 
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easily hydrolyzable bond, rendering them inert to typical phosphotriesterases.  A 
phosphotriesterase from Sphingobium sp. strain TCM1 (Sb-PTE) has recently been 
reported to catalyze the hydrolysis of organophosphorus flame retardants.  This enzyme 
was expressed in Escherichia coli, and the activity with a wide variety of 
organophosphorus substrates has been characterized. Sb-PTE exhibits catalytic activity 
against flame retardants, plasticizers, and industrial solvents.  
In this study, we use mass spectrometry and peptide mapping experiments, 
revealing the active site residues and reaction mechanism for Sb-PTE.  The proposed 
active site residues of Sb-PTE complex agreed quite well with the crystal structure that 
was published later.  The enzyme catalyzes the hydrolysis of substrates by activation of a 
nucleophilic water molecule for direct attack at the phosphorus center. 
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CHAPTER I 
  
INTRODUCTION AND LITERATURE REVIEW*  
 
1.1 Bacterial Phosphonate Metabolism    
 
1.1.1   Biological importance and industrial applications of phosphonates 
Phosphorus, an essential element for life, is a limiting nutrient in various 
ecosystems.  The most abundant phosphorus sources are orthophosphate and phosphate 
esters, which contain a C-O-P bond.  The C-O-P bond is part of DNA and RNA 
backbones, which are essential for the storage, transcription and expression of genetic 
information.  C-O-P bond is also key component of ATP which is most common cellular 
fuel.  However, organophosphonates may have been the predominant phosphorus source 
on early earth when oxygen was not a major component of air (1).  In contrast to the 
                                                 
* Part of this chapter is reprinted with permission from “Subunit Interactions within the Carbon–
Phosphorus Lyase Complex from Escherichia coli” by Zhongjie Ren, Soumya Ranganathan, Nathanael F. 
Zinnel, William K. Russell, David H. Russell, and Frank M. Raushel, Biochemistry 2015 54 (21), 3400-
3411, Copyright 2016 by American Chemical Society.   
 
 
Part of this chapter is reprinted with permission from “Interrogation of the Substrate Profile and Catalytic 
Properties of the Phosphotriesterase from Sphingobium sp. Strain TCM1: An Enzyme Capable of 
Hydrolyzing Organophosphate Flame Retardants and Plasticizers” by Dao Feng Xiang, Andrew N. Bigley, 
Zhongjie Ren, Haoran Xue, Kenneth G. Hull, Daniel Romo, and Frank M. Raushel, Biochemistry 2015 54 
(51), 7539-7549, Copyright 2016 by American Chemical Society.   
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orthophosphate and phosphate esters which contain a C-O-P bond, the C-P bond in 
organophosphonates is highly resistant to chemical hydrolysis, thermal decomposition 
and photolysis (2).   
Compounds containing a C-P bond constitute as much as 20% to 30% of the 
available phosphorus in nature (3).  The highly stable C-P bond in organophosphonates, 
such as lipids, exopolysaccharides and glycoproteins, stabilize the cell membrane 
structure and resist phosphatase hydrolysis.  Phosphonates are the main cellular 
phosphorus-containing compounds in several organisms.  For example, 50% of the 
phosphorus in the sea anemone Tealia could be found in a variety of phosphonates such 
as phosphonoglycoproteins, phosphonoglycans, and phosphonolipids (4), whereas 95% 
of phosphorus in egg cells of the freshwater snail Helisoma exists in the form of 2-
aminoethylphosphonate modified phosphonoglycans (5).  In addition, the 
organophosphonates are also widely used in the pharmaceutical and agricultural 
industry.  Fosfomycin, dehydrophos, and plumbemycin are broad spectrum antibiotics.  
Glyphosate, phosphinothricin tripeptide (bialaphos) and phosphonothrixin are common 
herbicides.   Alendronate is an effective drug for the treatment of osteoporosis (3).  The 
structural similarity of bioactive organophosphonates to phosphate esters and carboxylic 
makes them analogous inhibitors with high affinity which can compete with phosphate 
esters and carboxylic for binding to the active sites of corresponding enzymes (6).  In 
addition, several phosphonates antibiotics such as fosfomycin can cause irreversible 
inhibition through covalent modification of the active site of enzymes (7).  Phosphate 
esters and carboxylic group are involved in most of the biological process in cells, so 
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potential enzyme targets for phosphonate inhibitors are widespread in metabolic and 
regulatory pathways such as glycolysis, protein phosphorylation and carboxylation (8, 
9).  
Organophosphonates were initially studied in 1944 by Pikl who synthesized 
aminomethylphosphonic acid, and then Kosolapoff and Chavane successfully 
synthesized a series of amino and amino-substituted phosphonates (10).  Chavane 
predicted the natural existence of phophonates based on the inherent stability of the 
carbon phosphorus bond (11).  The occurrence of organophosphonates in biological 
systems was not discovered until 1959.  2‑aminoethylphosphonic acid (2‑AEP) was the 
first natural organophosphonate that was identified, which was isolated from an ether–
ethanol-extracted hydrolysate of rumen protozoa (12).  Today, natural and man-made 
phosphonates are found to be widespread in the environment, however, phosphonates 
were considered of only limited significance for a very long time.   
 
1.1.2   Bacterial biosynthetic pathways of phosphonates 
Recent studies suggest that organophosphonates play a major role in the marine 
phosphorus cycle (13).  In the total oceanic dissolved organic phosphorus, the share of 
organophosphonates can be up to 30 percent.  The biosynthetic pathways for 
organophosphonates are mostly conserved in their initial steps, considering the great 
diversity of natural phosphonates.  In the organophosphonate biosynthesis pathway, the 
initial carbon phosphorus bond formation occurs through the intramolecular 
rearrangement of phosphoenolpyruvate (PEP) to phosphonopyruvate (PnPy).  This 
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reaction is catalyzed by the enzyme phosphoenolpyruvate phosphomutase (PEP mutase) 
(Scheme 1) (14).  The thermodynamics of the reaction indicates that the product, 
phosphonopyruvate, is 500 fold less favorable than the substrate, phosphoenolpyruvate.  
To provide the thermodynamics driving force to push the reaction towards 
phosphonopyruvate, the initial reaction is usually followed by a coupled enzymatic 
reaction, catalyzed by phosphonopyruvate decarboxylase (Ppd), which converts 
phosphonopyruvate to phosphonoacetaldehyde (PnAA) (15).  In other cases, the 
condensation of phosphonopyruvate and acetyl-CoA serves as the coupled enzymatic 
reaction, and results in the formation of 2-phosphonomethylmalate.  This exergonic 
reaction is catalyzed by a homolog of homocitrate synthase, FrbC (16).   
 
 
 
Scheme 1.  Biosynthetic pathway for phosphonoacetaldehyde (PnAA) (3)   
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Scheme 2.  Proposed biosynthetic pathway for fosfomycin (3) 
 
Phosphonoacetaldehyde and 2-phosphonomethylmalate then go through a variety 
of further biochemical reactions; for example, in the biosynthesis of fosfomycin, 
phosphonoacetaldehyde (PnAA) undergoes further methylation to form 2-hydroxypropyl 
phosphonic (HEP) by the enzyme phosphonoacetaldehyde reductase (Scheme 2) (16).   
 
1.1.3   Regulation of bacterial phosphonate uptake and metabolism 
The uptake and catabolism of phosphonates is subject to the Pho regulon, which 
links the environmental phosphate sensor to gene expression, providing a sophisticated 
and adaptive response to phosphate availability in the environment.   The Pho regulon, 
negatively controlled by the phosphate level, includes eight different transcriptional units 
(17).  In the Pho regulon, the PstSCAB protein complex, an ATP-binding cassette 
(ABC) transporter, acts as the detector of environmental phosphate (18).  The 
organization of the PstSCAB protein complex is illustrated in Figure 1.  The PstSCAB 
protein complex is formed by four different subunits including two transmembrane 
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proteins (PstC and PstA), a cytoplasmic ATP binding protein (PstB) and a periplasmic 
phosphate binding protein (PstS).  If the environmental phosphate is insufficient, then 
PstS decouples from PstA and PstC, leading to a conformational change in the PstSCAB 
complex.  The conformational change is transmitted through the subunit PhoU to the 
membrane associated histidine kinase PhoR.  The detailed mechanism of transition is 
unknown.  PhoR can be switched into two forms, repressor and activator, which act as 
phosphatase and kinase of PhoB, respectively (18).   
 
 
 
 
 
Figure 1: Model of phosphate regulon signal transduction (19) 
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Under phosphate deficiency, PhoR serves as an activator by phosphorylating 
PhoB.  Upon phosphorylation, PhoB binds to the Pho box, which is a conserved DNA 
sequence, located 10 bp upstream of the Pho regulon.  The feature of the Pho box 
sequence is tandem repeats of a conserved 6-7 base pair motif.  The motif is separated by 
short a sequence which varies in different species.  Upon binding between PhoB and the 
Pho box DNA sequence, PhoB facilitates RNA polymerase binding onto the promoters 
in the Pho regulon to activate transcription of a series of genes that promote the uptake 
and catabolism of both varied phosphorus source under conditions of phosphate 
limitation (18). 
 
1.1.4   Bacterial degradation pathways of phosphonates 
The bacterial catabolism of phosphonates as an alternative phosphorus source has 
been widely studied.  Currently, three groups of distinct organophosphonate degradation 
enzymes or enzymatic pathways have been characterized, including the C-P lyase, 
phosphonate hydrolases, and an oxidative pathway (20).   
The first group of organophosphonate degradation enzymes is phosphonate 
hydrolase, including phosphonoacetaldehyde hydrolase (Pald), phosphonoacetate 
hydrolase (PAA) and phosphonopyruvate hydrolase (PPH).  Refereed as phosphonatase,  
This group of enzymes was firstly studied and has been referred as phosphonatase.  
Phosphonate hydrolases can specifically cleave the C–P bond of substrates containing an 
electron withdrawing β-carbonyl group that facilitates bond delocalization.  (Scheme 3) 
(21). 
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Enzymes in the phosphonate hydrolases group have evolved from varied protein 
superfamilies.  The phosphonate hydrolysis activity was firstly reported by Ternan NG 
and coworkers.  They identified phosphonopyruvate hydrolase (PPH) from cell free 
extracts of Burkholderia cepacia, which is capable of utilizing phosphonoalanine as a 
phosphorus source (22).  In the proposed reaction mechanism catalyzed by PPH, 
phosphonopyruvate is hydrolyzed into phosphate and pyruvate (Scheme 3a).  As a 
member of the PEP mutase/isocitrate lyase superfamily, PPH possesses a (β/α) 8-barrel 
structural fold.  Monomers of PPH can form homo-tetramers with the eighth helix 
inserted between two adjacent dimers.  The crystal structure of PPH has been solved 
with magnesium ion and oxalate binding within its active site (PDB id: 2DUA).  The 
Mg2+ in the active site attracts the phosphonopyruvate substrate to facilitate further 
hydrolysis.  The details of the proposed reaction mechanism are illustrated in Scheme 4.   
(23) 
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Scheme 3.  Typical reactions catalyzed by enzymes of phosphonate hydrolases group 
(24) 
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Scheme 4.  Mechanism of the reaction catalyzed by phosphonopyruvate hydrolase (PPH) 
from Variovorax sp.  Pal2. (25) 
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Scheme 5.  Mechanism of the reaction catalyzed by phosphonoacetate hydrolase (PAH) 
(26)  
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Scheme 6.  Mechanism of the reaction catalyzed by phosphonoacetaldehyde hydrolase 
(PaldH) (27)  
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Another member of the phosphonate hydrolase group, phosphonoacetate 
hydrolase (PAH) was firstly reported in Pseudomonas fluorescens, from bacteria isolated 
in the sludge of a laundry waste treatment plant.  The substrate, phosphonoacetate, is 
converted to phosphate and acetate under the catalysis of PAH (Scheme 3b).   
Phosphonoacetate is an intermediate of 2-aminoethylphosphonate (2-AEP) degradation 
pathway (28).  As a member of the alkaline phosphatase superfamily, PAH contains a 
binuclear metal center and a highly conserved threonine or serine residue at the active 
site.  In the proposed reaction mechanism, the conserved threonine or serine is recruited 
to attack the substrate to form a covalent intermediate bound to a phosphoryl group (28).  
Two different PAH enzymes have been structurally and functionally 
characterized from Sinorhizobium meliloti 1021 and P.  fluorescens 23F.  Both of these 
enzymes can be activated by Zn2+, but Zn2+ can be replaced by Mn2+ or Fe2+ in the active 
site for PAH from S. meliloti.  The structure of these enzymes has been determined for 
the apo-enzyme andr complexed with substrate/inhibitor (PDB id : 1EI6, 3SZY, 3T02, 
3SZZ, 3T00, 3T01) (29).  On the basis of these crystal structures, PAH possesses an 
unprecedented capping domain to shield the active site from solvent during the reaction.  
A detailed reaction mechanism for the PAH is illustrated in Scheme 5 (30). 
Phosphonoacetaldehyde hydrolase (PaldH) is also a member of the phosphonate 
hydrolase group.  The substrate, phosphonoacetaldehyde (Pald), is synthesized by the 
reaction catalyzed by 2-AEP-pyruvate transaminase, which coverts 2-AEP and pyruvate 
to L-alanine and the phosphonoacetaldehyde.  The phosphonoacetaldehyde is further 
hydrolyzed by PaldH to form phosphate and acetaldehyde as products (Scheme 4c) (20). 
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As a member of the haloalkanoic acid dehydrogenase (HAD) superfamily, Mg2+ 
in its active site will facilitate the covalent modification of an active site aspartate 
residue by the substrate(31).  There are several available structures for PaldH from 
Bacillus cereus: PaldH complexed with Mg2+ (PDB id: 1RQN), vinyl sulfonate (PDB id: 
1RQL), and a trapped covalently modified intermediate (PDB id: 2IOF) (32-34).  A triad 
of residues (lysine, histidine and aspartic acid) in the active site has been identified, 
based on structural and functional studies.  The lysine residue attacks the carbon atom of 
the carbonyl group of the substrate.  A water molecule is activated by the histidine 
residue to attack the substrate and cleaves the carbon phosphorus bond.  Then the 
phosphoryl group is transferred to the aspartate residue.  Details of the proposed reaction 
mechanism are summarized in Scheme 6 (20). 
Recently a new class of organophosphonate degradation pathway was found.  
The gene product of phnY (2-oxoglutarate dioxygenase) and phnZ (a novel Fe2+ 
dependent phosphonate oxygenase) catalyze an oxidative cleavage of 2-
aminoethylphosphonate (Scheme 7) (35).  Sequence homology studies indicates that 
PhnY belongs to the non-heme Fe (II)/a-ketoglutarate-dependent dioxygenase family 
and PhnZ is a member of the metal-ion dependent phosphohydrolase superfamily (36). 
The oxidative cleavage of 2-AEP is catalyzed by PhnY and PhnZ sequentially.  In the 
first step, 2-AEP is converted into 2-amino-1-hydroxyl ethylphosphonic acid (2-α-1-
HEP) under the catalysis of PhnY.  PhnY has very high specificity for the substrate 2-
AEP so it cannot catalyze the hydrolysis of other phosphonates (37).  The proposed 
mechanism of the reaction is shown in Scheme 8. 
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In the next step, PhnZ recruits molecular oxygen to oxidatively hydrolyze the 
carbon phosphorus bond of 2-α-1-HEP, yielding phosphate and glycine as products.  A 
binuclear iron center in the active site plays an essential role in the oxidation process of 
the substrate through the formation of a Fe (III)-superoxo species.  A detailed reaction 
mechanism for the hydrolysis of the C–P bond of 2-α-1-HEP is illustrated in Scheme 8 
(35).  
New biological pathways for phosphonate metabolism were also explored and 
studied. Fosfomycin is a widely used organophosphonate antibiotic. It is a secondary 
metabolite of some bacterial species such as Streptomyces wedmorensis, S. fradiae, S. 
viridochromogenes and Pseudomonas syringae (19).  It contains a C-P bond and an 
oxirane ring with its structure.  Previous studies indicated that bacteria Mesorhizobium 
huakuii was able to utilize fosfomycin as a sole carbon and phosphorus source (38).  The 
fosfomycin degradation pathway is initiated with the hydrolysis of oxirane ring to yield 
the (1R, 2R)-1,2-dihydroxypropylphosphonic acid (39).  Then (1R, 2R)-1, 
2-dihydroxypropylphosphonic acid is oxidized to form (R)-1-hydroxy- 
2-oxopropylphosphonic acid.  However, other reactions involved in fosfomycin 
degradation pathway are still unclear (19).  
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Scheme 7.  Oxidative cleave of 2-aminoethylphosphonate catalyzed by PhnY and PhnZ 
(35) 
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Scheme 8.  Proposed Reactions and Mechanisms for PhnY and PhnZ (35) 
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1.1.5   Discovery of bacterial C-P lyase pathway 
The major route for the metabolism of phosphonates is the C–P lyase pathway.  
The C-P lyase activity is very promiscuous.  It can hydrolyze a broad spectrum of 
phosphonates containing either activated or unactivated carbon phosphorus bonds.  The 
first evidence for the cleavage of unactivated C-P bonds was reported by Zeleznick et al 
in 1963.  They used methyphosphonate or ethylphosphonate as the sole phosphorus 
source for sustainable Escherichia coli growth (40).  The Frost laboratory revealed that 
ribosyl intermediates were invloled in the pathway in 1980s, despite unsuccessful 
attempts to purify the proteins in C-P lyase pathway (2).   
Although the activity of C-P lyase was identified in a variety of bacteria species, 
the enzymatic activity was never found in the cell free extracts (2).  This obstructed the 
effort of clarifying the chemical reactions of the C-P lyase pathway.  Several hypotheses 
had been proposed for the mechanism of enzymatic cleavage of the C-P bond (17, 40, 
41).  The first hypothesis proposed the hydrolysis of C-P bond via the oxidation of the α- 
carbon of alkyphosphonate forming α-hydroperoxy, α-hydroxy, α-keto, or phosphor-
monoesters (40).  However, there was no proposed intermediate identified in the 
followed studies (36-38).  The most distinctive feature of degradation of 
methylphosphonate is the ratio between the released molecular methane and the formed 
cellular phosphate is 1:1.  The ratio could be also apply to other alkyphosphonates 
forming corresponding alkanes such as ethane, propane, butane, pentane, and hexane.  In 
addition, further studies of products of C-P lyase pathway also revealed the presence of 
corresponding alkenes such as ethene, propene and butane (42). 
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The second hypothesis proposed a redox dependent radical based 
dephosphorylation mechanism (41).  In the first step, a phosphonyl radical is generated 
and then cleaved to form an alkyl radical and phosphate.  Then the alkyl radical abstracts 
a hydrogen to yield the corresponding alkane.  The presence of alkenes among 
degradation products suggested that the radical dependent mechanism was possible.  The 
radical based mechanism of the cleavage of C-P bond was also supported by later studies 
(43, 44).  However, alternative hypothesis proposed that the cleavage of C-P bond 
involved ATP or other nucleotides (44).  The identification of intermediate, α-1-
ethylphosphono-ribose, was the evidence that supported this hypothesis.  It suggested 
that nucleotides may react with the phosphoryl group of alkylphosphonates to form a 
ribose-phosphonate intermediate.  Despite these great efforts, enzymatic C-P bond 
cleavage in vitro has not been achieved until 2011(45).  
 
1.1.6   Gene organization and functions of enzymes in C-P lyase pathway 
The phn gene operon that is responsible for C-P lyase pathway was identified by 
Wash CT et al in 1990.  Up to 17 genes encoding PhnA to PhnQ was determined to be 
required for bacteria to utilize unactivated phosphonates as a sole phosphorus source by 
deletion analysis (46).  The identified genes were cloned, mutated and transformed into 
various plasmids by B. L. Wanner et al (35).  A collection of plasmids that contained 
genes from phn operon was also constructed by B. L. Wanner et al (41).  Plasmid 
libraries containing insertions of different length of DNA fragments from phn operon 
were transformed into E. coli host that contained a deletion of the phn locus, and these E. 
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coli strains were screened for ones that could utilize phosphonate as a sole P source.  A 
10.4 kB of DNA that is essential for complementation of a phn deletion mutant was 
identified.  This DNA fragment contains fourteen genes (phnCDEFGHIJKLMNOP).  
Further studies suggested that fourteen genes were transcribed as a single operon that is 
up-regulated by the PhoR/PhoB two-component signaling system (41).   
Three genes (phnCDE) encode an ATP-binding cassette (ABC) transport system 
for phosphonate.  Previous studies showed that phnCDE gene products provided active 
transport of 2-aminoethyl [32P] phosphonic acid into E. coli cells (41).  The PhnC 
protein is an ATP binding component of the ABC transporter system, PhnD is a 
periplasmic phosphonate binding protein, and PhnE is a trans-membrane protein (41).  
The PhnD protein also contains a signal sequence for transmembrane export to the 
periplasm.  Affinity analysis has shown that PhnD is able to bind phosphonates with a 
Kd as low as 5 nM (47).  DNA sequence analysis of the E. coli K-12 phn gene operon 
revealed that an 8 base pairs insertion mutation in the phnE gene leads to the cryptic 
phenotype of E. coli K-12 strain (48). 
Based on sequence similarity studies, PhnF is a transcriptional repressor protein 
of the C-P lyase pathway.  Seven genes (phnGHIJKLM) have been proposed to encode 
the essential cassette for carbon-phosphorus (C-P) lyase activity; and three genes 
(phnNOP) have been assigned to encode enzymes with auxiliary functions (19).  
The phnO gene was characterized to produce an aminoalkyl phosphonate-N-
acetyltransferase (49).   PhnO catalyzed the reactions through a sequential kinetic 
mechanism with acetyl-CoA binding first and then followed by aminoalkylphosphonate.  
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The thioester of acetyl-CoA was attacked by the amine of aminoalkylphosphonate 
forming a tetrahedral intermediate.  The intermediate was hydrolyzed to yield the 
product, N-acetylated aminoalkylphosphonate.  As a member of the Gcn5-related N-
acetyltransferases (GNAT) superfamily, PhnO unprecedentedly requires a divalent metal 
ion for catalysis. The phnO gene is essential for hydrolysis of 1-aminoalkylphosphonates 
such as aminomethylphosphonic acid and S-1-aminoethylphosphonate (49). 
  The product of phnN gene was identified as a ribosyl 1, 5-bisphosphokinase 
which can phosphorylate ribose 1, 5-bisphosphate to yield 5-phosphoribosyl α-D-1-
diphosphate (PRPP) (50).  Genetic studies have shown that phnN is not necessary for 
phosphonate utilization in E. coli, which may be attributed to the presence of PhnN 
redundant activity in the cells (41).  The fact that the substrate of PhnN, ribosyl 1, 5-
bisphosphate, is also found in cells without the presence of phosphonate in the 
surroundings suggests the existence of PhnN redundant activity in the cells (51).  
As a member of the metallo-β-lactamase superfamily, PhnP is a 
phosphodiesterase that can recycle a "dead-end" intermediate, 5-phospho-α-ribosy-l , 2-
cyclic phosphate, which is formed upon the cleavage of the C-P bond (52).  The 
structure of PhnP has been determined with inhibitor orthovanadate (PDB id: 3P2U).  
On the basis of the structural model and a Brønsted analysis of PhnP reactions, a 
mechanism for PhnP is proposed (Scheme 9).  In this mechanism, an attacking water 
molecule is activated by two manganese ions in the active site.  The water molecule is 
then further activated by deprotonation by D80 (52). 
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1.1.7   Essential reactions of cleavage of C-P bond  
Using methylphosphonate as a model substrate, the essential biochemical 
reactions for cleavage of C-P bonds were reconstituted in vitro (Scheme 10).  PhnI, a 
nucleosidase, catalyzes the displacement of adenine from ATP by methylphosphonate 
(MePn) to form ribose-1-methylphosphonate-5-triphosphate (RPnTP), in the presence of 
PhnG, PhnH, and PhnL.  In the second step, RPnTP is hydrolyzed by PhnM, a 
pyrophosphatase, to generate ribose-1-methylphosphonate-5-phosphate (PRPn), and in 
the last step PhnJ, a SAM radical enzyme, catalyzes the cleavage of C-P bond in PRPn 
to form molecular methane and ribose-1, 2-cyclic phosphate-5-phosphate (PRcP) (45).   
Anaerobic conditions are required for the reaction of the cleavage of C-P bond.   
Spectroscopy revealed the existence of a 4Fe-4S cluster within PhnJ. In addition, the 
requirement of the S-adenosylmethionine (SAM) for the reaction suggests that the C-P 
bond is cleaved via a typical radical SAM mechanism.  Three cysteine residues (Cys241, 
Cys244, and Cys266) take part in the formation of the Fe4S4 cluster, whereas Cys272 is 
supposed to participate the reaction as a thiyl radical.  The mechanism of the cleavage of 
carbon phosphorus bond has been proposed  (53).  A reduced Fe-S cluster cleaves SAM 
to generate a 5’-deoxyadenosyl radical intermediate.  Then a hydrogen atom on Gly-32 
will be abstracted by the radical intermediate to form a glycyl radical.  The radical will 
then transfer to Cys-272 to produce a thiyl radical.  To cleave the C-P bond, the thiyl 
radical attacks the methylphosphonate moiety of PRPn to form a transient radical 
intermediate.  The C-P bond will be hydrolyzed by the collapse of the transient radical 
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intermediate.  The final products are PRcP and methane.  The proposed reaction 
mechanism is presented in Scheme 11 (53).  
 
 
 
 
Scheme 9.  Proposed mechanism for the PhnP reaction (52) 
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Scheme 10.  Reactions of C-P lyse pathway in E.  coli (54) 
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Scheme 11.  Proposed mechanism for the reaction catalyzed by PhnJ (20) 
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As the product of PhnJ catalyzed reaction, PRcP will be further hydrolyzed by 
PhnP to ribose-1, 5-bisphosphate (RbP).  In the next step, RbP is converted to 5-
phosphoribosyl-1-pyrophosphate (PRPP) via the catalysis of PhnN (50).  The reactions 
of C-P lyase are illustrated in Scheme 10.   
 
1.1.8   Bacterial species variation of phn operon 
In different bacteria species other than E .coli, the organization of phn gene 
operon could also be different (55).  Studies of phn operon in different bacteria species 
reveals two possible organizations of the genes encoding the phosphonate transport 
proteins, either phnCDE, as in E. coli, Burkholderia pseudomallei, and the Pseudomonas 
stutzeri phn operon, or phnCDEE, with two distinct transmembrane proteins, as in 
Sinorhizobium meliloti, O. anthropi, Agrobacterium radiobacter, Mesorhizobium loti, 
Bradyrhizobium japonicum, Nostoc sp. strain PCC7120, and Trichodesmium erythraeum 
(55).  In addition, a new operon htx that is responsible for uptake and oxidation of 
hypophosphite and phosphonate was also identified in P. stutzeri htx (56).  The actual 
location of genes phnCDE(E) is not always upstream of the remaining genes in phn 
operon as E. coli.  In O. anthropi, M. loti, and B. pseudomallei, the position of 
phnCDE(E) genes are downstream of other genes in phn operon (57).  In S. meliloti, the 
phnCDE(E) genes are located far away from the remaining genes in phn operon.  In 
most species, phnCDE(E) genes are transcribed in the same direction as the remaining 
genes in C-P lyase pathway, however, in Nostoc sp. PCC7120, the phnCDE genesare are 
transcribed in a divergent direction (55). 
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In some species, phnGHIJKLM genes are not located as a contiguous gene 
cluster.  The location of the phnM gene is away from the phnGHIJKL genes in S.  
meliloti.  There are two copies of phnM in O.  anthropi and A.  radiobacter.  The 
location of phnO gene is downstream of and overlapping the phnL gene in S.  meliloti, 
O.  anthropi, A.  radiobacter, and M.  loti.  PhnO gene is located very far away from the 
rest genes of phn operon in Nostoc sp.  PCC7120 (5).   In many species, there is no phnP 
gene in their phn operon, but in all strains where phnP is absent, duf1045 gene is a 
substitute in phn operon (55).  This gene encodes an enzyme PhnPP which is a 5-
phosphoribosyl 1, 2-cyclic phosphate dihydrolase. PhnPP was isolated from the Gram-
positive organisms Eggerthella lenta and Clostridium difficile.  It hydrolyzes 5-phospho-
ribose-1, 2-cyclic phosphate at α-carbon of the ribose moiety to yield an intermediate, 
ribose-2, 5-bisphosphate.  And then ribose-2, 5-bisphosphate is hydrolyzed to ribose-5-
phosphate and inorganic phosphate (58). 
Despite the widely spread phn operon in Eubacteria, C-P lyase activity was also 
identified in a few archaeal species for phosphonate catabolism.  For example, the 
chromosomes of Halorhabdus tiamatea SARL4B (GenBank accession no. HF571520.1) 
(59), Haloquadratum walsbyi C23 (accession no. FR746099.1) (60), and 
Natronomonas moolapensis 8.8.11 (accession no. HF582854.1) (60) all contain 
phnGHIJKLM genes.  Located upstream of the phnG gene, but transcribed in a divergent 
direction, the three species contain three genes phnDCE (H. tiamatea) or four genes 
phnDCEO (H. walsbyi and N. moolapensis).  There were no phnN or phnP gene or 
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homolog identified in any archaeal organisms.  The physiological role of the phn operon 
is still unclear (55).  
 
1.1.9   Multi-protein complex formed by enzymes of C-P lyase pathway 
PhnG, PhnH, and PhnM have been expressed and purified via standard methods.  
However, PhnI, PhnJ, PhnK, and PhnL have only been expressed and purified as 
glutathione S-transferase (GST) conjugates(45).  The instability of these proteins in the 
absence of solubility tags has significantly hampered the structural elucidation of those 
enzymes responsible for phosphonate metabolism.  Among those enzymes, PhnH is the 
only protein that has been structurally characterized as a homodimer.  Although it 
displays a fold related to the pyridoxal-5’-phosphate-dependent transferases, the role of 
PhnH is still unclear (61). 
Zechel, Hove-Jensen, and colleagues have recently demonstrated that multi-
subunit fragments of the C–P lyase complex can be expressed from plasmids in E.coli 
and subsequently purified to apparent homogeneity.  Partial complexes containing PhnG 
and PhnI (PhnG-I); PhnG, PhnH, PhnI, and PhnJ (PhnG–H-I-J); and PhnG, PhnH, PhnI, 
PhnJ, and PhnK (PhnG-H-I-J-K) were expressed and purified in high yield with high 
solubility and stability without the need for solubility tags (62).   
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1.2 Bacterial Phosphotriester Metabolism    
 
1.2.1   Environmental concerns raised by the application of phosphotriesters  
Phosphotriesters are a group of organophosphates that were initially developed 
during World War II.  This group of compounds was first utilized as insecticides for 
crop protection (63).  The structure of this group of compounds is a phosphate center 
with three ester linked functional groups.  The chemical structures of common synthetic 
phosphotriesters are illustrated in Scheme 1.  The most well-known phosphotriesters are 
the neurotoxic nerve agents and insecticides such as paraoxon (compound 1 in Scheme 
12). These compounds can irreversibly inhibit the neural enzyme acetylcholine esterase 
by the enzymatic cleavage of a labile ester bond (64).  In recent years, a related group of 
organophosphotriesters has gained popularity for use as plasticizers and flame retardants 
in lubricants, durable plastics, and foams (65, 66).  Compounds such as tris(2-
chloroethyl) phosphate (compound 5 in Scheme 12) (65) and triphenyl phosphate (66), 
unlike the neurotoxic organophosphates, do not contain a labile ester bond but rather 
make use of the stable nature of these compounds to inhibit combustion and improve the 
performance of other organic compounds.  
While not neurotoxins, many of the flame retardants contain halogenated alkyl or 
aromatic esters and are known, or suspected, chemical carcinogens (66).  For example, 
tris (2-chloroethyl) phosphate could have adverse effects on the nervous system, 
digestive system, circulatory system and reproductive system of male rats and mice (67).  
These compounds are currently being produced at hundreds of metric tons per year (2, 
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3).  The contamination of the environment by organophosphorus flame retardants has 
become widespread, and these compounds are now considered to be major emerging 
pollutants (3). 
 
1.2.2   Bacterial degradation of phosphotriesters  
In various species of bacteria, natural and synthetic organophosphotriesters are 
hydrolyzed by phosphotriesterase (PTE) (68-71). To utilize the man-made 
organophosphotriesters as phosphorus source in the environment, bacteria evolved the 
ability to hydrolyze this type of compounds.  The structural similarity of the phosphoryl 
centers between synthetic and natural substrates may play an essential role for the 
development of the promiscuous activity towards synthetic organophosphortriesters (72).  
Structural models of PTEs from various species reveal different protein folding 
patterns of PTEs including TIM-barrel, β-lactamase, “pita-bread”, and β-propeller folds 
(73-77).  Despite the varied protein structural folds, PTEs are known to possess divalent 
metal center(s) to bind and activate substrates for hydrolysis (71, 74, 78, 79).  PTEs with 
different folding patterns hydrolyze the organophosphotriesters via different chemical 
mechanisms.  The enzymes with β-propeller folding are proposed to go through a 
covalent reaction intermediate, while the TIM-barrel and the “pita-bread” enzymes 
usually hydrolyze the substrate by direct attack of water/a hydroxide (80-82).  The 
chemical mechanism of phosphotriesterase with a β-lactamase fold is not unknown (83).  
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Scheme 12. Common synthetic organophosphotriesters 
 
 
 
1.2.3   Phosphotriesterase with TIM barrel fold  
As a member of the amidohydrolase superfamily, the structure and chemical 
mechanism of phosphotriesterases (PTE) with a TIM barrel fold are well studied.  This 
group of enzymes was first identified from the bacterium Pseudomonas diminuta (Pd-
PTE) and Flavobacterium sp. in phosphotriester contaminated soil (84, 85).  Other 
enzymes of this group were identified in different soil bacterial species such 
as Agrobacterium radiobacter (OpdA) and Chryseobacterium balustinum (86, 87).  The 
identified enzymes of this group share more than 90% sequence identity (88).  
Moreover, these enzymes also have very similar substrate profiles and kinetic 
parameters (88).  The X-ray structures of these enzymes revealed a distorted (β/α) 8 or 
TIM-barrel protein fold (88-91) (Figure 2A).  The fold of these proteins contains a core 
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barrel of eight α-helices and eight parallel β-strands.  The α-helices and β-strands in the 
barrel are connected to one another by flexible loops.  A binuclear metal center is ligated 
to histidine and aspartic acid residues in the active site that is located at the C-terminal 
end of the TIM-barrel (73).  The α-metal ion that is ligated two histidine and an aspartate 
is buried under the surface of the protein while the β-metal that is solvent accessible is 
ligated by two histidine residues (92, 93) (Figure 2B).  The active site is quite 
promiscuous for metal ions. Although the native enzyme contains Zn2+ in its active site, 
Cd2+, Mn2+, or Ni2+ can also result in active enzymes (78). 
The activity of this group of enzymes is very promiscuous.  It can hydrolyze a 
broad spectrum of phosphotriesters (83).  Containing an electron withdrawing phenolic 
leaving group, paraoxon is one of the best substrates (83).  The catalytic efficiency with 
paraoxon can be close to the limits of diffusion (94).  In addition, PTE is also able to 
hydrolyze phosphotriesters containing thiol linkages and halide bonds (83).  The broad 
substrate spectrum of this group of enzymes is proposed to be attributed to the 
promiscuity of the substrate binding site.  Three hydrophobic binding pockets on the 
surface of the enzyme can fit three ester groups of the phosphotriesters (95).  In the 
proposed catalytic mechanism of PTE with a TIM barrel fold, an activated water 
molecule directly attacks the phosphorus center of the substrate (Scheme 13) (89).  
Mutagenesis and kinetic studies of PTE have indicated that that the residues in the 
binding pockets determines the substrate specificity for PTE (96).  Based on the 
available structural information, catalytic efficiency for nerve agents and insecticides has 
been optimized by directed evolution (83).  
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Scheme 13. Proposed chemical mechanism of PTE with the TIM-barrel folding (97). 
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Figure 2: Crystal structure of PTE with TIM-Barrel folding. (PDB id: 1DPM). (A) TIM-
barrel fold of PTE. Metals in active site are shown as spheres.  (B) Metal binding site of 
PTE.  
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1.2.4   Phosphotriesterase with “pita bread” fold 
The best characterized enzyme of the group of phosphotriesterase with a “pita 
bread” fold is organophosphate acid anhydrase (OPAA) from Alteromonas sp. (71).  The 
overall architecture of this enzyme is a tetramer that can further be divided into two 
dimers (98).  A binuclear Mn2+ site is located in the central cleft of the "pita bread" fold 
at the C-terminal domain (Figure 3A).  The two Mn2+ ions are bridged by two 
carboxylate residues (98).  Based on the X-ray structure of OPAA, these two metals are 
proposed to be bridged by an additional hydroxide (98) (Figure 3B).  The proposed 
chemical mechanism of OPAA is illustrated in Scheme 14. The direct attack at the 
phosphorus center of the substrate by the bridging hydroxide is observed by O18 labeling 
mass spectroscopy and NMR analysis (77).  
 
 
 
 
Scheme 14.  Proposed chemical mechanism of PTE with the Pita-Bread fold (97). 
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Figure 3: Crystal structure of OPAA, a representative of PTE with a “pita-bread” fold 
(PDB id: 3l7G).  (A) Dimeric structure of OPAA.  One momomer is shown with in 
green and the other monomer is shown in red. Mn2+ is shown as a sphere.  (B) Expanded 
view of the OPAA metal center. 
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1.2.5   Phosphotriesterase with β-propeller fold 
Paraoxonase (PON1) and diisopropylfluorophosphatase (DFPase) are PTEs with 
a β-propeller fold.  These two enzymes were identified in mammalian serum and sea 
squid, respectively (99, 100).  Based on the crystal structures, DFPase and PON1 are 
Ca2+ containing enzymes with a six-bladed β-propeller fold (75, 101).  The X-ray 
structure of DFPase is illustrated in Figure 4.  Each propeller typically has four pleated 
β-strands.  Two Ca2+ are located in the water filled cleft at the center of the β-propeller.  
One Ca2+ is considered to stabilize the β-propeller fold and doesn’t participate the 
catalytic process (79).  This Ca2+ is ligated to aspartic acid or histidine residues as well 
as three water molecules. (Figure 4B) (79).  It is proposed to maintain the water network 
in the center of the six-bladed β-propeller fold (79).  The other Ca2+ is more solvent 
accessible and takes part in the catalytic process (79).  The proposed mechanism for 
phosphotriester cleavage by PON1 and DFPase is illustrated in Scheme 15.  In the 
proposed reaction mechanism, the reaction proceeds via a covalent enzyme bound 
intermediate (76, 80).  In the crystal structure of DFPase with a substrate analog bound, 
a conserved aspartate residue is aligned for backside attack to the phosphorus center of 
the substrate.  At the same time, a conserved histidine residue is located in an orientation 
towards the leaving group of the substrate (80). This histidine residue is proposed to 
serve as a base for the deprotonation of water molecule while the carboxyl group of the 
aspartic acid was proposed to attack the substrate yielding a phosphoacyl intermediate. 
The formation of a phosphoacyl intermediate was confirmed by 18O labeling mass 
spectrometry under single and multiple turnover conditions (80).  
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Scheme 15. Proposed catalytic mechanism for phosphotriesterase reaction catalyzed by 
PTE with β-propeller folding (97).  
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Figure 4: Crystal structure of DFPase, PTE with β-propeller folding (PDB id: 2GVV). 
Calcium ions are shown as spheres.  Catalytic calcium is shown in red while structural 
calcium is shown in yellow.  (A) Top down view of DFPase showing the 6 bladed β-
propeller structure.  (B) An extended view of DFPase metal center ligation. 
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1.2.6   Discovery of novel phosphotriesterases  
Due to the lack of a sufficiently labile leaving group, currently identified 
phosphotriesterases have little or no activity against organophosphorus flame retardants 
and plasticizers (88, 102-104). Two novel phosphotriesterase-like enzymes from 
Sphingomonas sp. strain TDK1 (Sm-PTE) and Sphingobium sp. strain TCM1 (Sb-PTE) 
have recently been reported to hydrolyze organophosphates that are not substrates for 
other phosphotriesterases, such as Pd-PTE or OpdA (103).  When this study was 
initiated, very little was known about these enzymes aside from their amino acid 
sequence and their dependence on the addition of divalent metal ions for catalytic 
activity.  In addition, there was no structural or mechanistic information available for 
either Sm-PTE or Sb-PTE, or any close homologue of known function.  
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CHAPTER II 
  
STRUCTURAL CHARACTERIZATION OF CARBON PHOSPHORUS MULTI-
PROTEIN COMPLEX*  
 
2.1   Introduction 
 
Phosphorus, an essential element for life, is a limiting nutrient in various 
ecosystems.  The most abundant phosphorus sources are orthophosphate and phosphate 
esters, which contain a C-O-P bond.  However, organophosphonates may have been the 
predominant phosphorus source on early earth when oxygen was not a major component 
of air (1).  In contrast to the orthophosphate and phosphate esters which contain a C-O-P 
bond, the C-P bond in organophosphonates is highly resistant to chemical hydrolysis, 
thermal decomposition and photolysis (2).  Compounds containing a C-P bond constitute 
as much as 20% to 30% of the available phosphorus in nature (3).  Phosphonates are the 
main cellular phosphorus-containing compounds in several organisms.  In addition, the 
organophosphonates are also widely used in the pharmaceutical and agricultural 
                                                 
* Part of this chapter is reprinted with permission from “Subunit Interactions within the Carbon–
Phosphorus Lyase Complex from Escherichia coli” by Zhongjie Ren, Soumya Ranganathan, Nathanael F. 
Zinnel, William K. Russell, David H. Russell, and Frank M. Raushel, Biochemistry 2015 54 (21), 3400-
3411, Copyright 2016 by American Chemical Society.   
 
Part of this chapter is reprinted with permission from “Structures of the Carbon-Phosphorus Lyase 
Complex Reveal the Binding Mode of the NBD-like PhnK” by Kailu Yang, Zhongjie Ren, Frank M. 
Raushel, Junjie Zhang, Structure 2015 24(1), 37-42, Copyright 2016 by Elsevier Inc.     
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industry.  Today, natural and man-made phosphonates are found to be widespread in the 
environment.  
The bacterial catabolism of phosphonates as an alternative phosphorus source has 
been widely studied.  Currently, three groups of distinct organophosphonate degradation 
enzymes or enzymatic pathways have been characterized, including the C-P lyase, 
phosphonate hydrolases, and an oxidative pathway (20).  The major route for the 
metabolism of phosphonates is the C–P lyase pathway.  The C-P lyase activity is very 
promiscuous.  It can hydrolyze a broad spectrum of phosphonates containing either 
activated or unactivated carbon phosphorus bonds.  Although the activity of C-P lyase 
was identified in a variety of bacteria species, the enzymatic activity was never found in 
the cell free extracts (2).  This obstructed the effort of clarifying the chemical reactions 
of the C-P lyase pathway.  Despite these great efforts, enzymatic C-P bond cleavage in 
vitro has not been achieved until 2011(45).   
The C-P lyase pathway is encoded by a 14-cistron phnCDEFGHIJKLMNOP 
operon.  Further studies suggested that fourteen genes were transcribed as a single 
operon that is up-regulated by the PhoR/PhoB two-component signaling system 
(41).Seven genes (phnGHIJKLM) have been proposed to encode the essential cassette 
for carbon-phosphorus (C-P) lyase activity (19).   Using methylphosphonate as a model 
substrate, the essential biochemical reactions for cleavage of C-P bonds were 
reconstituted in vitro.  PhnI catalyzes the displacement of adenine from ATP by 
methylphosphonate (MePn) to form ribose-1-methylphosphonate-5-triphosphate 
(RPnTP), in the presence of PhnG, PhnH, and PhnL.  In the second step, RPnTP is 
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hydrolyzed by PhnM, a pyrophosphatase, to generate ribose-1-methylphosphonate-5-
phosphate (PRPn), and in the last step PhnJ, a SAM radical enzyme, catalyzes the 
cleavage of C-P bond in PRPn to form molecular methane and ribose-1, 2-cyclic 
phosphate-5-phosphate (PRcP) (45).   
PhnG, PhnH, and PhnM have been expressed and purified via standard methods.  
However, PhnI, PhnJ, PhnK, and PhnL have only been expressed and purified as 
glutathione S-transferase (GST) conjugates(45).  The instability of these proteins in the 
absence of solubility tags has significantly hampered the structural elucidation of those 
enzymes responsible for phosphonate metabolism.  Among those enzymes, PhnH is the 
only protein that has been structurally characterized as a homodimer.  Although it 
displays a fold related to the pyridoxal-5’-phosphate-dependent transferases, the role of 
PhnH is still unclear (61).  Zechel, Hove-Jensen, and colleagues have recently 
demonstrated that multi-subunit fragments of the C–P lyase complex can be expressed 
from plasmids in E.coli and subsequently purified to apparent homogeneity.  Partial 
complexes containing PhnG and PhnI (PhnG-I); PhnG, PhnH, PhnI, and PhnJ (PhnG–H-
I-J); and PhnG, PhnH, PhnI, PhnJ, and PhnK (PhnG-H-I-J-K) were expressed and 
purified in high yield with high solubility and stability without the need for solubility 
tags (62).  
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2.2   Materials and Methods 
 
2.2.1 Materials 
LB broth was purchased from Research Products International Corporation.  The 
HisTrap and gel filtration columns were obtained from GE Healthcare.  Mini-
PROTEAN precast gels were purchased from Bio-Rad.  Bis-sulfosuccinimidyl suberate 
(BS3), immobilized pepsin resin, and trypsin were purchased from Thermo Scientific.  
The C18 reverse phase column was purchased from Waters Corporation.  D2O was 
obtained from Cambridge Isotope Laboratories.  All other buffers, purification reagents, 
and chemicals used in this project were purchased from Sigma/Aldrich, unless otherwise 
noted. 
 
2.2.2 Cloning and expression of C–P lyase complexes 
DNA containing the gene for PhnG through PhnK (his-PhnG-H-I-J-K and PhnG-
H-I-J-K-his) from E. coli was amplified from the strain BW5328/pGY3 (CGSC, Yale 
University).  For the his-PhnG-H-I-J-K construct, 5’-AGCTCGTCGAT GCGACA 
TATGCACGCAGATACCGCGACCCGCC-3’ and 5‘-TCAAGTGG ATCCT 
CAATTCTGCAAAACCGATGACACCAGCAGCTG-3’ were utilized as the forward 
and reverse primers, respectively.  For the PhnG-H-I-J-K-his construct, 5’-
AGCTCGTCGAT GCGACATATGCACGCA GATACCGCGACCCG CC-3’ and 5’-
TCAAGTCTCGAGATTCTGCAAAACCGATGACACCAG CAGCTG-3’ were utilized 
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as the forward and reverse primers, respectively.  The polymerase chain reaction (PCR) 
was performed using Platinum Pfx DNA polymerase (Life Technology) and the 
following reaction conditions: 5 min at 95 °C, followed by 30 cycles of 30 s at 95 °C, 30 
s at 66 °C, and 5 min at 72 °C.  The his-PhnG-H-I-J-K PCR fragment was subsequently 
digested by the restriction enzymes Nde1 and BamH1 (New England Biolabs).   
The digested DNA fragment was ligated to a pET-28b vector for expression with 
an N-terminus 6x-His-tag for purification.  The PhnG-H-I-J-K-his PCR fragment was 
subsequently digested by the restriction enzymes Nde1 and Xho1 (New England 
Biolabs).  The digested DNA fragment was ligated to a pET-24b vector for expression 
with a C-terminus 6x-His-tag for purification.  The DNA for the expression of his-PhnG, 
his-PhnH, his-PhnG-I, and PhnG-I-his (containing only PhnG and PhnI) and PhnG-H-I-
J-his (containing PhnG, PhnH, PhnI, and PhnJ) was cloned as previously described (45, 
62).   
 
2.2.3 Protein purification 
The plasmids for the expression of the various complexes of C–P lyase were 
transformed into Rosetta2 (DE3) pLysS cells (Novagen) by electroporation and plated 
on LB agar.  A single colony was used to inoculate 10 mL of LB medium containing 50 
μg/mL kanamycin and allowed to grow overnight at 37 °C (250 rpm agitation).  The 10 
mL culture was subsequently used to inoculate 1 L of LB medium and incubated (250 
rpm agitation) at 37 °C for 2–3 h until the OD600 reached ∼0.6.  The temperature was 
then reduced to 18 °C and the culture induced with 0.5 mM isopropyl-β-thiogalactoside 
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(IPTG).  The cells were harvested by centrifugation after 16–18 h of incubation and then 
stored at −80 °C.  The frozen cells were thawed and then resuspended (4:1, v/w) in 
buffer A (50 mM HEPES, pH 8.5, 150 mM NaCl, and 20 mM imidazole) containing 
0.10 mg/mL PMSF and a protease inhibitor cocktail.  The cells were disrupted by 
sonication, the insoluble debris was removed by centrifugation at 4 °C, and the 
supernatant solution applied to a 5 mL HisTrap (GE Healthcare) column.  The column 
was pre-equilibrated with 10 column volumes of buffer A, and the proteins were eluted 
with a gradient of buffer B (500 mM imidazole in buffer A).  The fractions were pooled 
and applied to a High Load 26/60 Superdex 200 prep grade gel filtration column (GE 
Healthcare), which was previously equilibrated with buffer C (buffer A without 
imidazole).  The fractions were pooled and analyzed by SDS-PAGE.  Typical yields for 
the PhnG-H-I-J-K C–P lyase complexes were ∼30 mg/L of culture.  Typical yields for 
the his-PhnG, his-PhnH, his-PhnG-I, PhnG-I-his, and PhnG-H-I-J-his fragments were 
∼18 and ∼25 mg per liter of culture, respectively.  The N-terminus His-tag was cleaved 
by Thrombin CleanCleave Kit (Sigma-Aldrich) following the manufacturer’s protocol. 
 
2.2.4 N-terminus protein sequencing 
The amino acid sequence and stoichiometry of the subunits of the two protein 
complexes were determined by amino terminus protein sequencing using a Procise 494A 
protein sequencer (Applied Biosystems).  Seven cycles of automated Edman degradation 
of the PhnG-I-his complex was performed.  The subunit stoichiometry was calculated by 
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comparing the relative protein concentration of each subunit after each cycle of Edman 
degradation. 
 
2.2.5 Analytical ultracentrifugation 
The molecular mass and oligomeric state of three C–P lyase complexes (his-
PhnG-I, his-PhnG-H-I-J, and his-PhnG-H-I-J-K) were characterized by sedimentation 
velocity using an Optima XL-A analytical ultracentrifuge (Beckman Instruments).  All 
experiments and analyses were conducted at the University of Texas Health Science 
Center, San Antonio, TX.  Samples of the C–P lyase complexes contained 10 mM Tris 
(pH 8.5), 150 mM NaCl, and 1.0 mM DTT.  The protein concentrations ranged from 
0.25 to 0.75 mg/mL, and the samples were centrifuged at 30000 rpm at 20 °C.  The 
density and relative viscosity of the buffers were calculated as 1.004700 g/mL and 
1.01418 mPa·s, respectively (14).  On the basis of the sequence of the C–P lyase 
complexes, the partial specific volume (vbar) of the protein complexes were calculated 
as 0.7272 mL g–1.  The absorbance of the samples was measured at 231 nm with a 50 s 
delay. 
 
2.2.6 ESI-MS measurements 
ESI MS measurements were acquired with a ThermoScientific Exactive Plus 
EMR.  In general, protein complexes were buffered with 50 mM ammonium acetate and 
loaded into an in-house pulled tip containing a platinum wire.  All mass spectra were 
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calibrated externally using a 1.0 μg/μL solution of cesium iodide.  The protein 
complexes were buffered exchanged into 50 mM ammonium acetate (pH 6.8) prior to 
analysis using Bio-Rad Micro Bio-Spin columns.  A potential of 1500–1800 V was 
applied to the spray tip and m/z was scanned from 900 to 16000.  Important instrument 
parameters used were: FT resolution was set to 17500, S-Lens RF = 200, S-Lens = 42 V, 
skimmer = 15 V, ion injection time was limited to 200 ms, AGC target set to 1000000, 
and 40 microscans were acquired.  Typical acquisition times were 4 min.  Source CID 
and HCD voltage were varied to either limit fragmentation or to promote it.   
The protein complex composition and stoichiometry were determined via mass 
differences observed in the intact MS analysis of the protein complex.  Obtained data 
were deconvoluted with Thermo Scientific Protein Deconvolution software.  Typical 
settings for the deconvolution were an m/z range of 2000–13000, output mass range 
20000–300000, 75 ppm mass tolerance, charge state range of 4–50, four iterations, 
minimum adjacent charges 4–7, and a resolution of 12374 at 400m/z.  Because of 
sample heterogeneity and the nature of the native spray analysis, it is estimated that all 
deconvoluted masses have an error of 400 ppm. 
 
2.2.7 Chemical cross-linking 
The chemical cross-linking agent BS3 was added to a solution of 20 μM his-
PhnG-H-I-J-K (50 mM HEPES, pH 8.5 and 150 mM NaCl) to a final concentration of 
2.5 mM and then incubated on ice for 2 h.  The reaction was quenched by Laemmli 
sample buffer (2% SDS, 10% glycerol, 120 mM Tris-HCl, pH 6.8) and subsequently 
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analyzed by SDS-PAGE.  The gel was stained with 3 mg/mL Coomassie brilliant blue 
R250 and then destained with a solution containing 30% methanol and 10% acetic acid.  
The sample was proteolyzed via the addition of trypsin using a previously described 
protocol (105).  The final samples were analyzed by LC-MS (Dionex nanoRSLC and an 
Orbitrap Fusion Tribrid mass spectrometer from Thermo Scientific).  Briefly, 1.0 μL of 
the digested protein sample was loaded onto a 75 μm × 15 cm Acclaim Pepmap C18 
column and eluted over 30 min with a total run time of 1 h.  The eluted peptides were 
introduced into the mass spectrometer and analyzed using the Orbitrap (OT) mass 
spectrometer in positive ion mode with the following settings: resolution 120 K, scan 
range 400–1500 m/z, maximum injection time 50 ms, AGC target 2 × 104, and S-lens 
RF level = 60.  Charge states from 2 to 7 were accepted, and targeting ions were 
excluded for 60 s.  MS/MS data were obtained using the HCD cell and fragment masses 
determined using the OT mass spectrometer at a resolution of 30 K.  The generated data 
were analyzed using the cross-linking identification software StavroX (version 3.4.5) 
(106).    
For the analysis of peptide masses from cross-linking experiments, a maximum 
mass deviation of 7 ppm and a minimal signal-to-noise ratio (S/N) of three were 
accepted.  The mass range was set as 200–5000 Da.  Decoy searches were also 
conducted with the same parameters using the reverse protein sequences to determine 
the false positive rate.  The results were evaluated by the StavroX software (106).   For 
scores larger than 76, the false-positive rate was less than 5%.  Candidate peptides with 
scores higher than 76 were selected and then manually checked before being assigned as 
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positives.  Additionally, carbamidomethylation of cysteine was taken into account as a 
fixed modification and oxidation of methionine was set as a varied modification.  Up to 
three missed-cleavage sites were utilized during data processing. 
 
2.2.8 Hydrogen/deuterium exchange 
The his-PhnG, his-PhnH, and his-PhnG-I protein complexes were concentrated to 
2.5 mg/mL and the his-PhnG-H-I-J-K complex was concentrated to 4.5 mg/mL.  
Deuterated buffers were prepared by removing water from the aqueous buffer containing 
50 mM HEPES (pH 8.5), 200 mM NaCl, and 2.0 mM TCEP using a centrifugal vacuum 
concentrator and then adding an equivalent volume of 99.9% D2O (Cambridge Isotope 
Laboratories, Inc.).  A total of 4.0 μL of the concentrated protein sample was diluted into 
36 μL of aqueous buffer for the undeuterated sample.  The deuterated samples were 
obtained by diluting 4 μL of protein into 36 μL of the deuterated buffer (90% 
deuteration) for various amounts of time (4 and 10 s, 1.0, 2.0, 5.0, 15, and 30 min, and 
1.0 h) at 0 °C.  The deuterium exchange reaction was quenched with 60 μL of ice-cold 
buffer containing 3.0 M urea and 50 mM TCEP at pH 2.1 to bring the final pH of the 
resultant mixture to pH 2.3–2.4 (17, 18).  A total of 50 μL of the quenched sample was 
added to 50 μL of immobilized pepsin resin (Thermo Scientific, USA).  The pepsin 
beads were preactivated by washing with 1% (v/v) trifluoroacetic acid in water, pH 2.0 
(107, 108).   
The digestion was carried out at ∼6 °C for 5 min with frequent vortexing.  The 
solution was then transferred to a 0.22 μm Ultrafree-MC GV centrifugal filter (EMD 
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Millipore), and the pepsin beads were removed by centrifugation at 8000 rpm for 30 s.  
The supernatant solution was divided into aliquots and immediately flash-frozen in 
liquid nitrogen and stored at -80 °C. 
The subsequent analysis by mass spectrometry was performed using a Thermo 
Scientific Q Exactive instrument within two to three days of sample preparation.  The 
samples were thawed on ice prior to injection to minimize back-exchange.  The peptic 
digests of his-PhnG, his-PhnH, his-PhnG-I, and his-PhnG-H-I-J-K were applied to a 2.1 
mm × 100 mm Symmetry C18 reverse-phased column (Waters Corporation, Milford, 
MA) using 0.1% (v/v) formic acid in water at a flow rate of 200 μL/min.  The peptides 
were eluted using a gradient of 8–55% acetonitrile over the course of 8 min.  The 
solvents and column were placed in an ice-bath throughout the experiment to reduce the 
back-exchange of deuterons during analysis.  A blank solution using acetonitrile was 
utilized between each sample to avoid peak carry-over between runs.  The mass 
spectrometer was calibrated using an LTQ ESI positive ion calibration solution from 
Thermo Scientific, USA.  The peptides were identified using the software Peptide 
Mapping (Thermo Scientific) with a mass tolerance of 10 ppm for the theoretical mass-
to-charge (m/z) ratios.  Oxidation of methionine was set as a possible modification.  The 
peptides were further confirmed by LC-MS/MS analysis on an Orbitrap Fusion Tribrid 
mass spectrometer from Thermo Scientific as described earlier.  The pepsin digestion 
provided sequence coverages of 88%, 83%, and 86% for the PhnG, PhnH, and PhnG-I 
complexes, respectively.  The PhnG-H-I-J-K complex had a sequence coverage of 89% 
for PhnG and PhnI and 83% for PhnH. 
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The deuterium content and centroid values of each peptide at various time points 
were calculated using the software HDExaminer (Sierra Analytics, Modesto, CA).  Each 
identified peptide was manually examined and validated.  It was assumed that the 
maximum number of exchangeable amides in a peptide is two less than the total number 
of amino acids in the peptide minus any proline residues (107-109).  The shifts in the 
centroid values for the deuterated samples were determined using the undeuterated 
sample as a control.  The various charge states of an individual peptide were used to 
calculate the deuterium level, and the values between them did not show much change.  
For regions of the proteins containing multiple overlapping peptides, a maximum of 
three overlaps encompassing the wider region were used in the analysis.  The peptide 
exchange plots were generated using MS-Excel.  The deuterated samples were not 
corrected for back-exchange, and all of the reactions were carried out under identical 
conditions. 
 
2.2.9  Homology modeling and secondary structure predictions 
The homology model for PhnK was created using the Intensive Mode of the web-
based structure prediction software Phyre2 (110) with the nucleotide-binding domain of 
a dipeptide ABC transporter (PDB id: 4FWI), which has a 32% sequence identity with 
PhnK.  For PhnG, PhnI, and PhnJ, the homology modeling was conducted using Swiss 
Model (111) and the secondary structure prediction was carried out using SABLE 
protein structure prediction server (111).   All protein structure figures were generated 
using Pymol (http://www.pymol.org). 
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2.2.10   Electron microscopy 
PhnG2H2I2J2K was diluted to 0.1 mg/mL with dilution buffer (50 mM HEPES, 
pH=8.5, 150 mM NaCl, 2 mM TCEP).  3 μL of the sample was applied to a C-Flat 
1.2/1.3 holey carbon grid at 16 °C with 100% relative humidity and vitrified using a 
Vitrobot Mark III (FEI).  The thin-ice areas that were expected to show clearly visible 
and mono-dispersed particles were imaged under an FEI Tecnai F20 cryo-electron 
microscope with a field emission gun (FEI) operated at 200 kV.  Data were recorded on 
a Gatan K2 Summit electron-counting direct detection camera (Gatan) in electron-
counting mode (112).  A nominal magnification of 25,000× was used, yielding a pixel 
size of 1.5 Å.  The beam intensity was adjusted to a dose rate of ∼10 electrons per pixel 
per second on the camera.  A 25-frame or 50-frame movie stack was recorded for each 
picture, with 0.2 s per frame for a total exposure time of 5 s or 10 s, respectively. 
 
2.2.11 Image processing 
Up to 967 collected image stacks were iteratively aligned and filtered based on 
the electron dose using Unblur (113).  A total number of 694 sum images were selected 
according to the visibility of particles and power spectra.  For particle picking, the sum 
images were first low-pass filtered to 15 Å to visualize particles unambiguously.  The 
Erase tool of e2boxer.py in EMAN2 (114) was used to erase bad areas that had junk or 
no particles.  Finally, the Swarm tool of e2boxer.py was used to semi-automatically pick 
492,889 particles using a box size of 120 pixels, during which the threshold for picking 
was interactively changed so that false-positive picking was minimized.  The coordinates 
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were imported into Relion (115) to extract the particles from the original sum images 
with a downscaling factor of 1, 2, or 4.  Reference-free 2D classification was performed 
in Relion to remove bad particles that cannot average well with each other, which 
generated a dataset of 294,203 particles.  We selected 3,956 particles with good contrast 
to generate an initial model using the PRIME routine in the SIMPLE package (116), 
which was low-pass filtered to 60 Å and used for the first round of unsupervised 3D 
classification in Relion.   
The 3D classification and refinement was performed hierarchically.  Briefly, in 
the first two rounds of 3D classification, particles were separated into three classes based 
on quality and the presence or absence of PhnK.  Up to 50,061 good particles from one 
class with PhnK were selected and further refined with C1 symmetry to produce the 
density map of PhnG2H2I2J2K.  A total number of 86,391 particles without PhnK were 
subjected to an additional round of 3D classification to separate them into three classes, 
which yielded 23,861 good particles in one class.  These 23,861 particles were further 
refined with C2 symmetry to produce the density map of PhnG2H2I2J2.  The particle 
images were downscaled by four times in the first two rounds of the 3D classification 
and downscaled by two times in the later 3D classification and refinement.  Refinement 
against the particles without downscaling, did not improve the final resolution of the 
maps.   
Blocres of the Bsoft package (117) was used to estimate the local resolution of 
the cryo-EM maps.  Our resolution is limited to 7.8 Å, which may be due to the flexible 
nature of the specimen. 
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2.2.12 Molecular modeling and map segmentation 
Fitting of models into the density map was done in UCSF Chimera (118).  The 
correct handedness of the density maps of PhnG2H2I2J2 and PhnG2H2I2J2K were initially 
determined by docking the crystal structure of PhnH (PDB id : 2FSU) (61) into the 
original maps and the maps with the flipped handedness.  The crystal structure of PhnH 
fitted into the flipped maps with all the secondary structures matching, confirming that 
the original maps should have their handedness flipped.  A homology model of PhnK 
was built using SWISS Model (119) based on an nucleotide binding domain (PDB id : 
4U00) (120).  The location of PhnK was determined by the difference map between 
PhnG2H2I2J2K and PhnG2H2I2J2.  Moreover, the homology model of PhnK fitted the 
difference map with all of the secondary structures in place, confirming the correct 
location of PhnK in PhnG2H2I2J2K.  Segmentation of the PhnG2H2I2J2 core was done 
using Segger (121) in UCSF Chimera based on the crystal structure of PhnG2H2I2J2 
(PDB id: 4XB6).  The electrostatic surface of the models was calculated using the APBS 
module (119)in UCSF Chimera. 
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2.3   Results 
 
2.3.1 Characterization of PhnG-I 
Two different contructions were prepared for the expression of a complex that 
contained only PhnG and PhnI.  The first of these had a polyhistidine purification tag at 
the N-terminus of PhnG, and the second had the polyhistidine tag at the C-terminus of 
PhnI.  The calculated molecular masses for the subunits within these two complexes are 
as follows: PhnG (16,524 Da), his-PhnG (18,688 Da), PhnI (38,852 Da), and PhnI-his 
(39,917 Da).  Both of these complexes migrated as a single peak upon elution from a 
calibrated Superdex 200 10/300 GL gel filtration column (GE Heathcare) (data not 
shown), and the approximate molecular mass was determined to be 140 ± 26 kDa. 
The molecular mass for the his-PhnG-I complex was also determined using 
analytical ultracentrifugation and ESI mass spectrometry.  For the his-PhnG-I complex, 
the sedimentation coefficient (Sw=20) of 5.89 S corresponds to an apparent molecular 
mass of 115.8 ± 1.7 kDa at a protein concentration of 0.25 mg/mL.  The sedimentation 
velocity experiment was also conducted at a protein concentration of 0.75 mg/mL and a 
van Holde–Weischet analysis (122) indicated that the oligomeric state of his-PhnG-I did 
not change at the higher protein concentration.  Under native ESI conditions, the his-
PhnG-I complex exhibited charge states in the gas phase with a range of +21 to +25 and 
a mass of 115, 300 Da (Figure 5).  CID fragmentation of the his-PhnG-I complex 
resulted in the loss of a PhnG monomer and a mass corresponding to PhnGI2 (96,600 
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Da), as well as the appearance of a mass at 56,000 Da that corresponds to PhnGI, 
indicating that PhnG and PhnI form a heterodimer (Figure 6). 
 
 
 
 
Figure 5:  Native ESI of the PhnG2I2 complex.  The upper figure is the raw data obtained 
using 75 V of energy in the HCD cell and 50 V of energy in the source region.  The 
bottom figure is the deconvoluted data using the isotope clusters from the upper mass 
spectrum of the complex, which represents the +19 to +23 charge states of the complex. 
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Figure 6:  Fragmentation of the PhnG2I2 complex.  Upper figure is the raw data obtain 
using 75 V of energy in the HCD cell and 75V of energy in the source region.  The 
bottom figure is the deconvoluted data.   
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Figure 7: The ratio between the amino acid of PhnG and PhnI in seven N-terminus 
protein sequencing cycles.   
 
 
Table 1: The ratio between the amino acid of PhnG and PhnI in seven N-terminus 
protein sequencing cycles.   
 
Cycle number  1 2 3 4 5 6 7 
PhnG amino acids M H A D T A T 
PhnI amino acids M Y V A V K G 
Ratio - 1.09 1.02 1.00 0.87 0.84 1.04 
Average ratio 0.98 
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Stoichiometry of the PhnG-I-his complex was addressed by N-terminus amino 
acid sequence analysis.  After seven rounds of N-terminus amino acid sequencing, the 
ratio of the amino acids specific for PhnG to that for PhnI averaged 0.9 ± 0.1 (Figure 7 
and table 1). The data from the first round of sequencing was dismissed due to the 
overlap methionine of these two proteins.  Therefore, the apparent stoichiometry of the 
two subunits contained within the PhnG-I-his complex is ∼1:1.  Given the mass of the 
his-PhnG-I complex determined from analytical ultracentrifugation (115,800 Da) and 
ESI mass spectrometry (115,770 Da), it is concluded that the stoichiometry of the 
complex containing only PhnG and PhnI is PhnG2I2. 
 
2.3.2 SDS electrophoresis of PhnG2I2 
The subunit composition of the PhnG2I2 complex was confirmed by SDS-PAGE, 
and the identity of each band was verified by in-gel digestion with trypsin and mass 
spectroscopy (Figure 8).  The intensity of the Coomassie Blue staining for each of the 
two separated subunits of PhnG2I2 was measured using a Gel Doc EZ System 
densitometer (BioRad).  For the PhnG2I2-his complex, the relative staining intensity for 
subunits PhnG and PhnI-his was 1.00:1.22 (56.3:68.6) and 1.00:1.07 (56.4:60.3) for his-
PhnG2I2 (Table 2).  When the his-tag was removed by proteolysis with thrombin, the 
relative staining intensity for these two subunits was similar (1.00:1.17).  Because the 
molecular mass ratios for the two subunits are 1.00:2.42 (for PhnG and PhnI-his) and 
1.00:2.09 (for his-PhnG and PhnI), PhnG stains approximately twice as dense per amino 
acid as does PhnI under these conditions. 
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Figure 8.  SDS-PAGE separation of the subunits contained within the C–P lyase 
complexes from E. coli.  Lane 1: his-PhnG2I2.  Lane 2: his- PhnG2H2I2J2.  Lane 3: his- 
PhnG2H2I2J2K.  All protein complexes were diluted to 2 mg/mL in sample buffer (65.8 
mM Tris-HCl, pH 6.8, 2.1% SDS, 26.3% (w/v) glycerol, 0.01% bromophenol blue) and 
loaded onto a Bio-Rad mini-protean precast gel.  The gel was stained by Coomassie 
Brilliant Blue and the relative intensity of each band quantified using a Gel Doc EZ 
System densitometer (BioRad). 
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2.3.3 Characterization of PhnG-H-I-J 
The complex that contains subunits PhnG, PhnH, PhnI, and PhnJ was cloned 
with a polyhistidine tag at the C-terminus of PhnJ.  This complex migrated as a single 
homogeneous peak after elution from a gel filtration column (data not shown).  The 
approximate molecular mass for this complex was determined to be 243 ± 38 kDa using 
a calibrated Superdex 200 10/300 GL gel filtration column (GE Heathcare).  Two 
species were identified by ultracentrifugation at a protein concentration of 0.25 mg/mL.  
The major component (79.9%) exhibited a Sw20 value of 9.43 S and an estimated 
molecular mass of 218.8 ± 7.4 kDa.  The minor component (19.1%) had an Sw20 value 
of 7.90 S with an estimated molecular mass of 191.0 ± 9.1 kDa.  The sedimentation 
velocity experiments were also conducted at a higher protein concentration (0.75 
mg/mL), and these experiments indicated that the PhnG-H-I-J-his complex aggregated at 
the higher protein concentration during the ultracentrifugation process. 
The subunit composition of the PhnG-H-I-J-his complex was confirmed by SDS-
PAGE, and the identity of each band was verified by in-gel digestion with trypsin and 
mass spectroscopy (Figure 7).  The intensity of the Coomassie Blue staining for each of 
the separated subunits was measured, and the relative staining intensities for subunits 
PhnG, PhnH, PhnI, and PhnJ-his are listed in Table 2.  From the relative staining 
intensities for PhnG and PhnI in this complex (1.19–1.28), we can conclude that these 
two subunits are in a ratio of 1:1 because this is essentially the same ratio as found in the 
PhnG2I2 complex (1.17). 
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Table 2.  Relative staining intensities in PhnG-I, PhnG-H-I-J and PhnG-H-I-J-K 
 
  PhnG PhnI 
PhnG- I 56.0 65.5 
PhnG-I-his 56.3 68.6 
Phn his-G-I 56.4 60.3 
Average  56.2 64.8 
Ratio 1.00 1.15 
 
  PhnG PhnH PhnI PhnJ G:I 
PhnG-H-I-J 27.6 11.2 35.4 25.9 1:1.28 
PhnG-H-I-J-his 26.0 13.5 31.0 29.5 1:1.19 
PhnG-H-I-J-K 28.4 11.8 35.8 27.0 1:1.26 
PhnG-H-I-J-K-his 29.7 11.3 38.0 27.9 1:1.28 
his-PhnG-H-I-J-K 28.5 9.3 36.5 24.8 1:1.28 
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Figure 9: Native ESI of the PhnG2H2I2J2 complex.  The upper figure is the raw data 
obtained using 10 V of energy in the HCD cell and 10 V of energy in the source region.  
The bottom figure is the deconvoluted data utilizing the isotope clusters from the upper 
mass spectrum of the complex, which represents the +28 to +33 charge states of the 
complex. 
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Figure 10: Fragmentation of the PhnG2H2I2J2 complex.  Upper figure is the raw data 
obtain using 75V of energy in the HCD cell and 75V of energy in the source region.  The 
bottom figure is the deconvoluted data. 
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Under native ESI conditions, the parent mass of the PhnG-H-I-J-his complex was 
measured to be approximately 222,200 Da (Figure 9).  In an effort to elucidate the 
subunit composition of this complex, the collisional energy was raised as high as 200 V 
and the resulting deconvoluted fragment masses of 197,900, 166,300, 144,000, 111,100, 
94,500, and 55,600 were obtained (Figure 10).  These fragments correspond to the 
sequential loss of PhnH (21.0 kDa), PhnJ-his (32.8 kDa), PhnH (21.0 kDa), PhnJ-his 
(31.7 kDa), PhnG (16.5 kDa), and PhnI (38.9 kDa).  PhnGI is the smallest fragment that 
was observed.  These results are consistent with the formation of PhnHJ and PhnGI 
heterodimers in the complex and that the overall composition for this complex is 
PhnG2H2I2J2. 
 
2.3.4 Characterization of PhnG-H-I-J-K 
The complex composed of PhnG through PhnK was cloned and subsequently 
expressed with a polyhistidine tag at either the N-terminus of PhnG or the C-terminus of 
PhnK.  Both of these complexes migrated through a calibrated gel filtration column as a 
single peak (data not shown) with an estimated molecular mass of 285 ± 46 kDa.  The 
subunit compositions of the two PhnG-H-I-J-K complexes were confirmed by SDS-
PAGE, and the identity of each band was verified by in-gel digestion with trypsin and 
mass spectroscopy (Figure 7).  To estimate the stoichiometry of the subunits contained 
within these two complexes, the relative Coomassie Blue staining intensities for PhnG, 
PhnH, PhnI, and PhnJ were compared to the relative staining intensities for these same 
subunits in the complex that contains only four subunits (Table 1).  Within experimental 
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error, the relative staining intensities for PhnG, PhnH, PhnI, and PhnJ contained within 
the PhnG2H2I2J2 complexes matched those contained within either of the complexes that 
contained all five subunits.  Therefore, the PhnG2H2I2J2 core is retained within the two 
complexes that now contain PhnK. 
The molecular mass of the PhnG-H-I-J-K complex was estimated using 
analytical ultracentrifugation.  At a protein concentration of 0.25 mg/mL, the Sw20 
value was determined to be 8.94 S for the PhnG-H-I-J-K-his complex with a calculated 
molecular mass of 236.9 ± 8.3 kDa.  The sedimentation velocity experiments were also 
conducted at a protein concentration of 0.75 mg/mL and a van Holde–Weischet analysis 
indicated that the oligomeric state of PhnG-H-I-J-K-his was constant at the two protein 
concentrations.  The mass of the PhnG-H-I-J-K-his complex was also determined using 
ESI mass spectrometry.  Under native ESI conditions, the PhnG-H-I-J-K-his complex 
enters the gas phase with charge states of +30 to +36, corresponding to a mass of 
249,700 (Figure 11), a value that is consistent with that determined by analytical 
ultracentrifugation.  Using 75 V of source fragmentation energy and 45 V in the HCD 
cell, the mass at 249,200 most likely represents the PhnG2H2I2J2K -his complex 
(calculated mass = 245,144) and that at 221,300 represents the PhnG2H2I2J2 complex 
(calculated mass = 216,234) and the loss of PhnK-his (calculated mass = 28,910).  The 
mass at 196,234 represents the loss of PhnHJ (calculated mass = 52,741) to give 
PhnG2HI2JK (calculated mass = 192,403).  The mass at 168,598 represents the 
PhnG2HI2J complex with the loss of PhnK (Figure 12). 
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Figure 11: Native ESI of the PhnG2H2I2J2K complex.  The upper figure is the raw data 
obtained using 13 V of collision energy in the HCD cell and 10 V of energy in the 
source region.  The bottom figure is the deconvoluted data utilizing the isotope clusters 
from the upper mass spectrum of the complex, which represents the +30 to +36 charge 
states of the complex. 
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Figure 12: Fragmentation of the PhnG2H2I2J2K complex.  Upper figure is the raw data 
obtain using 75V of energy in the HCD cell and 45V of energy in the source region.  The 
bottom figure is the deconvoluted data. 
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2.3.5 Structural analysis by chemical cross-linking 
The contact regions for interaction of the subunits contained within the 
PhnG2H2I2J2K complex were probed by chemical cross-linking.  Cross-linking was 
initiated with the homobifunctional reagent bis-sulfosuccinimidyl suberate (BS3) that 
can form a linkage of up to 11.4 Å between the ε-amino groups of lysine residues or the 
free amino group of the N-terminus (123).  The products of the cross-linking reactions 
with PhnG2H2I2J2K -his were separated by SDS-PAGE, and the results are presented in 
Figure 13.  Four prominent high molecular mass cross-linked protein complexes of 
approximately 47 (band 1), 70 (band 2), 87 (band 3), and 110 kDa (band 4) were formed 
after incubation with BS3.  Two bands of higher molecular mass at approximately 125 
and 165 kDa were also formed but are less distinct.   
The cross-linked proteins were excised from the gel and subjected to in-gel 
digestion with trypsin and characterized by LC-ESI/MS.  On the basis of the mass 
spectrometry data, the 47 kDa band contains one copy each of PhnG (17 kDa) and PhnJ 
(31 kDa), the 70 kDa band contains one copy each of PhnI (39 kDa) and PhnJ, and the 
87 kDa band contains one copy each of PhnG, PhnI, and PhnJ.  The bands at 110, 125, 
and 165 kDa contain mixtures of PhnG, PhnI, and PhnJ.  No cross-linked proteins were 
identified to contain PhnH or PhnK. 
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Figure 13: SDS-PAGE of the BS3-initiated cross-linking of those proteins contained 
within the various carbon–phosphorus lyase complexes.  The left lane represents the 
separation of the subunits contained within the PhnG2H2I2J2K complex prior to the 
addition of BS3.  The middle lane is a standard molecular mass protein ladder (Bio-
Rad).  The rightmost lane represents the separation of cross-linked proteins after the 
addition of BS3 to the PhnG2H2I2J2K complex.  Four prominent cross-linked bands were 
labeled as 1, 2, 3, and 4 from the bottom to the top. 
 72 
 
Table 3: Identification of Specific Crosslinking Site of PhnG-H-I-J-K C-P Lyase 
 
 
 
M+H+ Dev. 
(ppm) 
Sequence 1 Protein 1 Sequence 2 Protein 2 Site 
P1 
Site 
P2 
Band1  3010.457 -2.65 [DKQHAER] PhnG {ANLSGYNFAYLD
EQTKR] 
PhnJ K2 {0 
Band2  2501.295 2.34 [NFFKR] PhnJ [GGEKAIDAAHAL
QESR] 
PhnI K4 K4 
3214.425 -1.95 {MYVAVKGG
EK] 
PhnI [QQSEAKNQ} PhnJ {0 K17 
2857.428 -3.37 {mYVAVK] PhnI {ANLSGYNFAYLD
EQTKR] 
PhnJ K6 {0 
1930.028 1.53 [NFFKR] PhnJ {MYVAVKGGEK] PhnI K4 K6 
Band3  2501.291 0.65 [NFFKR] PhnJ [GGEKAIDAAHAL
QESR] 
PhnI K4 K4 
3010.47 1.68 [DKQHAER] PhnG {ANLSGYNFAYLD
EQTKR] 
PhnJ K2 {0 
3137.47 -3.92 {MMHADTAT
R] 
PhnG [MDMmPALQLFG
AGREKR] 
PhnJ {0 K16 
2167.068 -0.97 [QQSEAKNQ} PhnJ {mYVAVKGGEK] PhnI K6 {0 
Band4 3010.47 1.68 [DKQHAER] PhnG {ANLSGYNFAYLD
EQTKR] 
PhnJ K2 {0 
7691.662 -6.61 {mMHADT 
ATRQHW 
MSVLAHS 
QPAELAAR] 
PhnG [EMPMPYGWGT 
GGIQLTAS 
VIGESDVLKVID 
QGADDTTNAVSIR
] 
PhnJ {0 K27 
2501.280 0.65 [NFFKR] PhnJ [GGEKAIDAAHAL
QESR] 
PhnI K4 K4 
1930.021 -2.17 [NFFKR] PhnJ {MYVAVKGGEK] PhnI K4 K6 
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Figure 14: ESI-MS/MS analysis of the cross-linked peptides contained within the 
PhnG2H2I2J2K complex.  The peptide 
88DKHAER94 from PhnG and the peptide 
2ANLSGNYFAYLDEQTKR18 were cross-linked through Lys-89 from DKHAER and 
the N-terminus of ANLSGNYFAYLDEQTKR.   
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The cross-linked proteins were excised, proteolyzed with trypsin, and then 
analyzed by LC-ESI-MS/MS to identify the specific cross-linking sites.  The purified 
peptides were subjected to high-energy collision dissociation (HCD).  A representative 
example of an MS/MS spectrum of a triply charged ion at m/z 1004.16 (corresponding to 
an M + H+ = 3010.46) is provided in Figure 14.  The daughter ion spectrum exhibited 
most of the y-ion series for two peptides from PhnG (β-peptide, residues 89–95) and 
PhnJ (α-peptide, residues 2–18).  The y16β and y5α ions indicate that Lys-89 of PhnG 
and the N-terminus of PhnJ are covalently linked to one another.  A similar analysis was 
conducted to identify all of the other cross-linked peptides, and the identity of the cross-
linked peptide pairs are presented in Table 3. 
In addition to the intermolecular cross-links between different protein subunits, 
there were several intramolecular cross-links contained within PhnI and PhnJ.  In all of 
the cross-linking experiments, only peptides from PhnG, PhnI, or PhnJ were identified.  
There was no trace of PhnH or PhnK in the cross-linked proteins.  However, further 
analysis of the ESI-MS data identified several internally cross-linked peptides and 
individual lysine residues within PhnH and PhnK that were labeled with the cross-
linking reagent.  For example, Lys-38 from PhnH was derivatized with BS3.  In PhnK, 
the N-terminus, Lys-127, and Lys-220 were labeled with BS3 and an internal cross-link 
was identified between Lys-19 and Lys-49. 
2.3.6 Structural analysis by hydrogen/deuterium exchange 
Hydrogen/deuterium exchange experiments were carried out on PhnG, PhnG2I2, 
and PhnG2H2I2J2K from the C–P lyase complex in an attempt to determine those regions 
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of PhnG that are most affected by the association with PhnI.  It was assumed that those 
portions of PhnG that interact directly with PhnI will exhibit a change in the rate of H/D 
exchange in either PhnG2I2 or PhnG2H2I2J2K relative to the H/D exchange profile for 
PhnG alone.  Reduced rates of H/D exchange may also be observed for those portions of 
PhnG that become more structured in either of these two complexes than in the isolated 
subunit alone.  A difference of 10% or more in the exchange rate between any two 
protein complexes is considered significant.  The overall coverage of peptides from 
PhnG that were detected by mass spectrometry in all three complexes was approximately 
87%.   
The time course for the exchange of deuterium from solvent incorporated into the 
peptide 68TRAAVRLTDGTLGYS82 from PhnG is presented in Figure 15.  The time 
courses for H/D exchange within PhnG alone indicate that many regions of the protein 
undergo H/D exchange very rapidly.  This is especially true for those regions of PhnG 
that extend from residues 28–79 and from residues 116–124 (Figure 16).  All of the 
peptides identified for PhnG, PhnG2I2, and PhnG2H2I2J2K exhibit EX2 kinetics for 
deuterium uptake (124-126).  Bimodal isotopic distribution spectra, which indicate the 
presence of local or global unfolding through EX1 kinetics, were not observed for any of 
the peptides of PhnG or PhnI (58, 59). 
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Figure 15: Time course for the uptake of deuterium by the peptide 
68TRAAVRLTDGTLGYS82 from PhnG as measured by ESI-MS after 0, 4 s, 5 min, and 
1 h. 
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Figure 16: Differential deuterium exchange for the peptides contained within PhnG 
alone and the same peptide contained within PhnG2I2.  The incubation times are as 
follows: 4 s (◆), 10 s (■), 1 min (▲), 2 min (□), 5 min (●), 15 min (●), 30 min (■), 
and 60 min (◆). 
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Figure 17: Differential deuterium exchange for the peptides contained within PhnG and 
PhnI for the complexes PhnG2I2 and PhnG2H2I2J2K.  The peptides differing in exchange 
pattern between the two complexes are highlighted in red.  The incubation times are as 
follows: 4 s (◆), 10 s (■), 1 min (▲), 2 min (□), 5 min (●), 15 min (●), 30 min (■), 
and 60 min (◆). 
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There are significant differences in the rates of deuterium exchange for those 
peptides from PhnG when this protein is contained within the PhnG2I2 or PhnG2H2I2J2 
complexes.  These differences are graphically depicted in the representative times 
courses for comparable peptides in Figure 16.  For the peptides that encompass residues 
16–23, 28–36, and 98–111, there are essentially no differences in the time courses for 
the uptake of deuterium by PhnG alone and PhnG contained within the PhnG2I2 
complex.  These results are in stark contrast to the significant differences in the 
exchange profiles for peptides that encompass residues 47–79 and 68–97 (Figure 16). 
The H/D exchange profiles for the PhnG and PhnI subunits contained within the 
PhnG2I2 and PhnG2H2I2J2K complexes are quite similar to one another (Figure 14).  For 
PhnG, there are virtually no differences in the exchange rates for portions of the protein 
when this complex is embedded in either PhnG2I2 or PhnG2H2I2J2K.  For PhnI, the only 
regions exhibiting differential deuterium exchange profiles between the two complexes 
are the peptides contained within PhnI that encompass residues from 33–41, 81–85, and 
109–130 (Figure 17).   
These peptides show slightly more protection in the PhnG2H2I2J2K complex than 
in the PhnG2I2 complex.  H/D exchange analysis of PhnH alone was carried out and 
compared with the peptides from PhnH obtained from the PhnG2H2I2J2K complex to 
help identify those regions of PhnH that undergo structural variations upon complex 
formation.  A total of 23 common peptides, spanning 83% of PhnH, were identified.  
From the deuterium uptake plots for the PhnH peptides in the individual subunit and the 
PhnG2H2I2J2K complex, many regions along the entire length of PhnH are more 
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protected in the PhnG2H2I2J2K complex (Figure 18).  The N-terminus region of PhnH, 
which comprises the dimerization interface in the crystal structure of PhnH, is 
represented by the peptides encompassing residues 6–18, 7–18, 19–24, and 19–31.  This 
region exhibits significant reduction in deuterium exchange in the PhnG2H2I2J2K 
complex as compared to the individual subunit of PhnH.  A major difference in 
deuterium exchange profile is also observed in the region connecting α-helix D with a 
disordered loop and stretches up to β-strand β5 for the peptides spanning residues 110–
123 (peptides 107–122 and 110–123).  A high degree of differential exchange is also 
observed in the region extending from residues 136–146 as illustrated by the peptides 
136LRLTGAG142, 136LRLTGAGIAE145, and 136LRLTGAGIAEE146 (Figure 18).    
This region extends from β-strand β6 and connects through a disordered loop 
region to β-strand β7 (Figure 19).  Finally, the C-terminus region of PhnH, illustrated by 
the peptides encompassing residues 157–173, 159–173, and 183–194 are more protected 
in the complex compared to the PhnH alone (Figure 18). 
 
 
 
 
 81 
 
 
 
Figure 18: Differential deuterium exchange for the peptides contained within PhnH 
alone and the same peptides contained within the PhnG2H2I2J2K complex.  The 
incubation times are as follows: 4 seconds (blue square); 10 seconds (red square); 1 
minute (green triangle); 2 minutes (purple cross); 5 minutes (blue circle); 15 minutes 
(light blue square); 30 minutes (orange circle); 60 minutes (pink square). 
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Figure 19: Crystal structure of PhnH.  (A) Cartoon representation of PhnH dimer.  The N 
and C terminus ends are labeled for each monomer.  The dimer interface region 
undergoing differential exchange is circled.  The dashed lines connecting two regions of 
the proteins indicate disordered regions not modeled in the crystal structure.  These 
disordered regions undergo differential exchange between individual subunit of PhnH 
and in the PhnG2H2I2J2K complex.  (B) Topology diagram of PhnH.  The N and C 
terminus regions are labeled; structural regions are labeled and the numbers indicate the 
residue range spanning each region.  Red cylinders represent α helices and blue arrows 
represent β--‑strands.  Coordinates taken from PDB id: 2FSU. 
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2.3.7 Co-existence of PhnG2H2I2J2 and PhnG2H2I2J2K  
The purified complexes were vitrified and imaged (Experimental Procedures).  
The collected movie stacks, from an electron-counting direct detection camera (112), 
showed clear particles and strong power spectra after aligning the frames within each 
movie (Figures 19B and 19C).  A total of 492,889 particles were semi-automatically 
picked, and subsequently classified with reference-free two-dimensional (2D) 
classification and unsupervised three-dimensional (3D) classification in Relion.  Two 
populations of particles were identified and reconstructed into two density maps, which 
correspond to the PhnG2H2I2J2 (core complex) and PhnG2H2I2J2K (core complex bound 
with PhnK), respectively.  These two maps were similar except for an extra lobe of 
density in one of them (Figure 19D).  Differences in the extra density were also observed 
in the reference-free 2D class averages calculated from all particles (Figure 19E).  This 
extra density was later confirmed as the PhnK subunit of the PhnG2H2I2J2K complex.  
Further refinements against the separated particles yielded the cryo-EM density maps of 
PhnG2H2I2J2 and PhnG2H2I2J2K, both at 7.8 Å resolution, based on the gold-standard 
Fourier shell correlation.  Local resolution was estimated, showing most regions of the 
maps were at a resolution range between 7 and 8 Å (Figure 19D).  At this resolution, the 
protein secondary structures were clearly visible. 
The existence of a complex missing PhnK, in the purified sample expressed from 
a plasmid containing the phnGHIJK genes, is consistent with previous native gel 
electrophoresis and mass spectrometry experiments, suggesting the loose binding of 
PhnK to the core complex PhnG2H2I2J2.  The fact that PhnG2H2I2J2 and PhnG2H2I2J2K 
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co-exist in the same sample apparently hindered previous trials for the crystallization of 
PhnG2H2I2J2K (127). 
 
2.3.8 Architecture of PhnG2H2I2J2 with or without PhnK bound 
The 3D density maps of the PhnG2H2I2J2 and PhnG2H2I2J2K complexes measure 
110 Å × 70 Å × 100 Å and 110 Å × 110 Å × 100 Å, respectively (Figure 20).  The 
common part of these two complexes is the PhnG2H2I2J2 core.  The core retains the same 
architecture after PhnK binding.  In both density maps, the two copies of PhnG, PhnH, 
PhnI, and PhnJ are arranged in a head-to-tail fashion in a sequence of H-J-I-G as labeled 
in Figure 19B.  While the cryo-EM maps were independently determined and not biased 
by the recently determined crystal structure of PhnG2H2I2J2 (Experimental Procedures), 
the crystal structure fits well into the cryo-EM density map of the core complex 
PhnG2H2I2J2 with matching secondary structures (Figure 20C). 
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Figure 20: Cryo-EM analysis reveals the co-existence of PhnG2H2I2J2 and PhnG2H2I2J2K 
(A) The series of the enzymatic steps of C-P lyase.  (B) A region of a representative 
micrograph showing the particles of PhnG2H2I2J2 and PhnG2H2I2J2K with a defocus of 
1.2 μm.  The scale bar denotes 500 Å.  (C) Power spectrum of the same micrograph in 
(B).  The white dashed curve shows the Nyquist at 3 Å.  (D) 3D density maps of 
PhnG2H2I2J2 (left) and PhnG2H2I2J2K (right).  The maps were colored based on the local 
resolutions.  (E) Projections of the two maps compared with the reference-free class 
averages in two representative orientations.  The Euler angles were based on the 
EMAN2 convention.  Yellow arrows indicate the location of PhnK. 
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Figure 21: Architecture of PhnG2H2I2J2 without or with PhnK bound (A and B) front and 
bottom view of PhnG2H2I2J2.  In (A), the groove on the core complex PhnG2H2I2J2 is 
labeled.  In (B), the gray ellipse denotes the two-fold symmetry axis, and the two purple 
polygons denote the two identical binding sites for PhnK.  (C) The crystal structure of 
PhnG2H2I2J2 fitted into the cryo-EM map of PhnG2H2I2J2 in the same orientation as (B).  
The red circles and squares denote the positions of Gly32 and Cys272 of PhnJ, 
respectively.  (D and E) Front and bottom view of PhnG2H2I2J2K in the same 
orientations as (A) and (B), respectively.  (F) The crystal structure of PhnG2H2I2J2 and 
the homology model of PhnK fitted into the cryo-EM map of PhnG2H2I2J2K in the same 
orientation as (E). 
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2.3.9 Two identical binding sites for PhnK on PhnG2H2I2J2 
The binding site for PhnK is located on α helix 6 (residue 147–158) and a nearby 
loop (residue 227–230) of PhnJ.  We term this loop the “chock loop” as it may stabilize 
the binding of PhnK like a chock.  Two PhnJ subunits in the core complex provide two 
identical binding sites for PhnK (purple polygons in Figure 20C).  These two binding 
sites are approximately 50 Å away from each other.  Noticeably, between these two 
binding sites lies a negatively charged groove, which was previously proposed as the 
PhnK-binding region based on a low-resolution density map of PhnG2H2I2J2K from 
negative stain EM and protein sequence conservation (127).  However, the entire groove 
is exposed to solvent and not in contact with PhnK in our cryo-EM map of 
PhnG2H2I2J2K (Figure 21). 
Even though the core complex provides two identical binding sites for PhnK, 
only one copy of PhnK was found to bind (Figures 20C–19E and 21).  PhnK is 
homologous to the conserved NBD of proteins in the ABC transporter family.  Like 
NBDs, PhnK consists of a helical domain and a RecA-like domain.  It has all of the 
sequence motifs (Walker A, Walker B, ABC signature, A-loop, D loop, Q-loop, and 
switch H-loop) of the NBD (Figure 22A) (128, 129).  A sequence alignment of PhnK 
with other structurally characterized NBDs is presented in Figure 24.  NBDs are known 
to interact with a transmembrane domain or protein (TMD) through its helical domain 
(130).  The L-loop of the TMD inserts into a cavity around the helical domain of the 
NBD, which forms the major interaction between NBD and TMD (131).  In contrast, 
PhnK, an NBD-like protein, interacts with the cytoplasmic protein complex 
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PhnG2H2I2J2.  This interaction is via a helix-turn-helix motif (residues 100–120 
containing the α helices 3 and 4) within the helical domain of PhnK to bind to α helix 6 
and chock loop of PhnJ (Figures 22B and 23A).   
When PhnK binds to PhnJ, the cavity of PhnK is completely exposed to solvent.  
The chock loop of PhnJ may instead provide additional support to block the movement 
of PhnK.  The binding interface between PhnK and PhnJ shows complementary 
electrostatic surface potentials.  At the interface, PhnK exhibits a net positive charge 
while PhnJ exhibits a negative charge (Figure 23B).  Attempts to dock a second copy of 
PhnK, in the same conformation as the first one, to the empty binding site in 
PhnG2H2I2J2K, resulted in considerable collision between their RecA-like domains, 
which prevents the simultaneous binding of two PhnK subunits. 
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Figure 22: PhnK is an NBD-like protein and interacts with PhnJ (A) Secondary structure 
of PhnK with the NBD motifs labeled.  The symbols ∗ and # label the sites for the 
interactions between PhnK and PhnJ.  (B) One PhnK binds to the core complex with the 
models fitted in the map.   
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Figure 23: (A) Electrostatic surface potentials at the interface of PhnJ and PhnK (B) One 
PhnK binds to the core complex with the NBD motifs color labeled.   
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Figure 24: Sequence alignment of PhnK, PhnL with NBDs in the ABC transporter 
family using CLC sequence viewer (CLC bio, QIAGEN). Binding of PhnK Exposes the 
Active Site Residue Gly32 
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Figure 24 (Continued)  
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Figure 24 (Continued)  
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The universally conserved Gly32 of PhnJ was proposed to generate a stable 
glycyl radical enzyme that supports multiple turnovers without further SAM 
consumption (53).  In the core complex, the two Gly32, each from one subunit of PhnJ, 
are symmetrically located on the two sides of the complex.  Both of these glycine 
residues are buried in PhnJ near the interface between PhnJ and PhnH.  In the map of 
PhnG2H2I2J2K, the density burying Gly32 of PhnJ shows striking difference between the 
two copies of PhnJ (Figure 33).   
On the side where there is no PhnK bound (apo side), the density burying Gly32 
is stronger than the corresponding density on the side where there is a PhnK bound 
(bound side), indicating the interaction between PhnJ and PhnH in the apo side is tighter 
than in the bound side.  On the apo side, the residue Gly32 is hidden, as in our cryo-EM 
density map of PhnG2H2I2J2 (Figure 33A).  On the bound side, the α helices 5 and 6 of 
PhnJ move away from PhnH, disrupting the molecular interaction between PhnJ and 
PhnH to expose the active site residue Gly32 (Figure 33B).  On the apo side, the density 
of α helices 5 and 6 of PhnJ matches well with the crystal structure, while on the bound 
side, the density of α helices 5 and 6 of PhnJ is shifted relative to the crystal structure.  
This shift indicates there is a structural rearrangement in this region to reveal the active 
site underneath. 
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2.4   Discussion 
2.4.1 Stoichiometry of the C–P Lyase complexes 
Three different protein complexes from the carbon–phosphorus lyase enzyme 
were expressed, purified, and characterized by gel electrophoresis, analytical 
ultracentrifugation, N-terminus protein sequencing, and high-resolution mass 
spectrometry.  For the complex that contains only PhnG and PhnI, the results are 
consistent with an equal mixture of the two subunits and an overall stoichiometry of 
PhnG2I2.  In the complex that contains these two subunits, in addition to PhnH and PhnJ, 
the results are consistent with a stoichiometry of PhnG2H2I2J2.  For the complex that 
contains five different subunits, the complex contains two copies of PhnG, PhnH, PhnI, 
and PhnJ, plus a single copy of PhnK (PhnG2H2I2J2K).   
These results suggest that PhnG and PhnI associate to form a central 
heterodimeric core (PhnG2I2) that is required prior to the binding of two additional 
copies each of PhnH and PhnJ (PhnHJ) to facilitate the assembly of PhnG2H2I2J2.  The 
largest complex is subsequently formed by the binding of a single copy of PhnK.  The 
proposed assembly pathway for the formation of the PhnG2H2I2J2 and the PhnG2H2I2J2K 
complexes is further supported by the mass spectrometry results where individual 
subunits are progressively dissociated from the central core complex.  With the 
PhnG2H2I2J2 complex, we observed the sequential dissociation of PhnH, PhnJ, PhnH, 
PhnJ, PhnG, and PhnI. 
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Figure 25: Cross-linking map of the PhnG2H2I2J2K complex.  All of the cross-linked 
residues are highlighted in red, while all of the residues that participate in a monolinkage 
are highlighted in blue.  Two residues that were reported to be key residues within the 
active site of PhnJ (Gly-32 and Cys-272) are highlighted in green.  The cross-linking 
bonds are depicted as straight lines between different cross-linking sites.  The internal 
cross-linked bonds are presented as a curve connecting two lysine residues.  
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Figure 26: Solvent exposed lysine residues and the N-termini of the PhnG2H2I2J2 
complex. (A) Solvent exposed lysine residues and N-termini that participate in the 
formation of crosslinked bonds.  (B) Solvent exposed lysine residues and subunit N-
terminus that are labeled by a mono-link.  (C) Solvent exposed lysine residues and 
subunit N-terminus that are not modified by mono-link or cross-link.  
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2.4.2 Chemical cross-linking 
Chemical cross-linking experiments were conducted to identify those subunits 
that are physically able to contact one another, and these results are graphically 
illustrated in Figure 25.  There are nine identified cross-linked bonds including the inter-
subunit and intra-subunit cross-links in the PhnG2H2I2J2K complex.  In addition, seven 
residues are found to be modified by a mono-link.  However, there are 16 additional 
lysine residues that are not modified by the cross-linking reagent.  According to the X-
ray structure of PhnG2H2I2J2, most of the residues that are connected by a cross-linked 
bond or singly modified are located on the surface of the complex while the majority of 
the unlabeled lysine residues are buried inside the complex (Figure 26).  These results 
indicated that the N-termini or lysine residues with high solvent accessibility are reacted 
more readily by the cross-linking reagent.    
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Figure 27: The formation of salt bridge between the unlabeled lysine residues that are 
the surface and the adjacent aspartic or glutamic acid residues.  (A) Lys-165 and Glu-
265 are from subunit PhnI. PhnI is colored green and PhnJ is colored blue.  (B) Lys-176 
and Glu-148 are from subunit PhnJ.  PhnJ is colored green. (C) Lys-87 and Asp-177 are 
from subunit PhnI.  PhnI is colored green.   
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2.4.2.1 Unlabeled lysine residues of PhnG2H2I2J2  
In PhnG2H2I2J2 complex, there are 14 lysine residues that are not modified.  
Based on the X-ray structure, most of the unmodified lysine residues are buried inside 
the complex.  However, three lysine residues (Lys-176 of PhnJ, Lys-165 of PhnI and 
Lys-87 of PhnI) are found on the surface of the complex (Figure 26C). These three 
residues can form a salt bridge with an adjacent aspartic acid or glutamic acid residue 
(Figure 27), which may prevent these lysine residues from being labeled by the cross-
linking reagent.  The side chain orientation of Lys-176 and Glu-148 of PhnJ cannot be 
aligned as a salt bridge in the crystal structure of PhnG2H2I2J2 (Figure 27B).  However, 
the distance between α-carbons of these two residues is 12 Å, which is shorter than the 
maximal length for the formation of a salt bridge, 15 Å. The maximal length is 
calculated by the sum of the maximal length of a salt bridge, 4 Å, the side chain length 
of a lysine residue, 6 Å and the side chain length of a glutamic residue, 5 Å.  Potentially, 
a salt bridge could be formed between these two residues.  In addition, Lys-165 of PhnI 
is on a flexible loop (average B-factor 41 Å2) that extends into the solvent, this residue 
may have been involved in an inter-complex crosslinking which was removed from the 
sample by SDS-PAGE before mass spectrometry analysis. 
 
2.4.2.2 Cross-linked or mono-linked modifications of subunit PhnG  
The N-terminal methionine and Lys-89 of PhnG are shown to be cross-linked 
with lysine residues of subunit PhnJ.  There are no other mono-linked labeled or 
unlabeled lysine residues on PhnG.  The N-terminus of PhnG is not located at the 
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interface between PhnG and PhnJ, despite the identification of cross-linked bonds 
between the methionine at the N-terminus of PhnG and the two lysines (Lys-211 and 
Lys-67) of PhnJ.  However, these two lysine residues are located at the interface 
between PhnG and PhnJ.  Lys-67 is exposed to the solvent while Lys-211 is buried by 
the interacting subunit PhnG.  The distance between the N-terminus of PhnG and these 
two lysine residues from PhnJ is as long as 50 Å, a distance that is much longer than the 
maximal length of a cross-linked bond between these residues.  The N-termini of PhnG 
is at an unstructured sequence with high mobility. The average B-factor of this region is 
49 Å2 while the average B-factor of the whole complex is around 29 Å2.  The formation 
of these cross-linked bonds must therefore be attributed to conformational changes 
within the complex.    
Lys-89 of PhnG and the N-terminus of PhnJ were shown to be connected by a 
cross-linked bond.  In the X-ray structure, the distance between Lys-89 of PhnG and the 
N-terminal alanine of PhnJ is 29 Å, obviously longer than the maximal length of the 
cross-linked bond, 20Å (Figure 28).  The maximal length of a lysine to N-terminus 
crosslinked bond is calculated by taking the sum of the arm length of the cross-linking 
reagent (11.5 Å), the side chain length of a lysine residue (6.5Å) and the length of 
carbon nitrogen bond of the N-terminal alanine (1.5 Å).  However, the N-terminus of 
PhnJ is at the end of a flexible loop.  The average B-factor value of this loop is as high as 
45 Å2, compared with an average B-factor value 29 Å2 for the whole protein complex.  It 
is possible that the loop is subject to a conformational change, which could reduce the 
distance between Lys-89 of PhnG and the N-terminus of PhnJ. 
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Figure 28: The distance between Lys-89 of PhnG and N-terminus of PhnJ in the 
PhnG2H2I2J2 complex. A cross-linked bond was identified connecting Lys-89 of PhnG to 
N-terminus of PhnJ by mass spectrometry analysis.  Subunit PhnJ is colored green and 
subunit PhnG is colored red.  The distance between the α-carbons of these two residues 
was measured as 28.5 Å.   
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Figure 29: Lys-23 and Lys-38 of PhnH in the PhnG2H2I2J2 complex. A potential salt 
bridge is observed between Lys-23 of PhnH and Glu-117 of PhnJ. The distance between 
the ε-amino group and carboxylate group is 2.8 Å.  PhnH is colored red and PhnJ is 
colored green.  
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2.4.2.3 Cross-linked or mono-linked modifications of subunit PhnH 
There are two lysine residues (Ly-23 and Lys-38) on subunit PhnH, however, no 
cross-linked peptides were identified for these two sites.  A mono-linked modification 
was found on Lys-38.  According to the crystal structure, Lys-38 is solvent exposed and 
located away from the interface between PhnH and PhnJ (Figure 29).  The closest lysine 
residue on PhnJ is 33 Å away from Lys-38, which is longer than the maximal cross-
linked length between two lysine residues of 25 Å.  The maximal length of the lysine to 
lysine crosslinked bond is calculated by the sum of the arm length of the cross-linking 
reagent (11.5 Å) and side chain length of two lysine residues (13.0 Å).  Moreover, there 
are two α-helices between these two residues, blocking the formation of a cross-linked 
bond.  Located at the interaction region between PhnH and PhnJ, Lys-23 is able to form 
a salt bridge with Glu-177 of PhnJ, which could hinder a cross-link or mono-link 
modification to this lysine residue.   
 
2.4.2.4 Cross-linked or mono-linked modifications of subunit PhnI and PhnJ 
There are three mono-linked labeled lysine residues of PhnI and PhnJ, identified 
by cross-linking mass spectrometry analysis.  In the X-ray structure, Lys-156 and Lys-
190 of PhnJ are located at the solvent exposed surface, far away from the protein-protein 
interaction region.  Lys-283 of PhnI is buried inside the complex but it can be solvent 
accessible through a short hydrophilic channel.  
Four cross-linked bonds were located at a solvent exposed region of the interface 
between PhnI and PhnJ (Figure 30).  Four residues (Lys-10 of PhnI, Lys-87of PhnJ, N-
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terminus of PhnJ and N-terminus of PhnI) were shown to be connected with each other 
by the cross-linking reagent.  In the X-ray structure, the distance between Lys-87 and N-
terminal alanine from PhnI is 9 Å, which is shorter than the maximal length of the cross-
linked bond, 20 Å.  The distance between Lys-87 from PhnJ and Lys-10 from PhnI is 18 
Å, which is also shorter than the maximal length of the cross-linked bond, 25 Å.  The 
distance between other crosslinked sites is longer than the maximal length of a cross-
linked bond (25 Å for lysine to lysine cross-link, 20 Å for lysine to N-terminus cross-
link and 14.5 Å for N-terminus to N-terminus cross-link), which could be attributed to 
the flexibility of the N-terminus of PhnJ and PhnI.  The N-terminus to N-terminus cross-
link is calculated by taking the sum of two carbon nitrogen bond (3.0 Å) and the length 
of the crosslinked bond (11.5 Å). The average B-factors for these two N-terminus loops 
of PhnI and PhnJ are 45 Å2 and 49 Å2, respectively.  Lys-279 of PhnJ is not included in 
the X-ray structural model so the precise distance between this residue and N-terminal 
methionine of PhnI could not be measured.  However, Ala-278, the residue located 
before Lys-279, is included in the crystal structure.  The distance between the α-carbon 
of Ala-278 of PhnJ and N-terminus of PhnI is 16 Å, which is shorter than the maximal 
length of a cross-linked bond, taking the length of side chains and amide bond into 
consideration (Figure 31).  
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Figure 30: The distance between lysine and N-terminus residues at the interface between 
PhnI and PhnJ in the PhnG2H2I2J2 complex.  PhnI is colored yellow and PhnJ is colored 
blue. Other subunits are colored green.  The N-terminal methionine and Lys-10 of PhnI 
are labeled as 1 and 2, respectively.  Lys-87 and the N-terminal alanine of PhnJ are 
labeled as 3 and 4, respectively.  The distance between the α-carbons of two residues 
where a cross-linked bond was as follows, residue 1 to residue 2: 16.5 Å; residue 2 to 
residue 3, 18.1 Å; residue 3 to residue 4, 8.7 Å and residue 4 to residue 1, 40.7 Å.   
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Figure 31: The distance between Ala-278 of PhnG and the N-terminus of PhnI in the  
PhnG2H2I2J2 complex. The distance between the α-carbons of these two residues was 
measured as 16.2 Å.  A cross-linked bond was identified connecting Lys-279 of PhnG to 
N-terminus of PhnI by cross-linking mass spectrometry analysis.  Subunit PhnJ is 
colored blue and subunit PhnI is colored green.  The distance between the α-carbons of 
these two residues was measured as 16.2 Å.   
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2.4.2.5 Cross-link or mono-link modification of subunit PhnK  
We identified an internal cross-link between two lysine residues and the labeling 
of two single lysine residues (Lys-127 and Lys-220) within PhnK.  This result indicates 
that the region containing these two lysine residues (Lys-19 and Lys-49) must be close 
to each other in the complex.  Although the lysine residues in the homology model of 
PhnK appear to be on the protein surface, no peptides of PhnK were cross-linked to any 
other subunit.  Based on the cryo-EM structural model of PhnG2H2I2J2K, these residues 
are not involved in the interaction between PhnK and the other subunits. Due to the 
resolution limitation, an accurate distance between the intra-linked two lysine residues 
cannot be determined.  However, the homology model of PhnK indicates that residues 
Lys-19 and Lys-49, which are internally cross-linked, are separated by a distance of 
about 20 Å, which is shorter than the maximal length (25 Å) of a cross-linked bond 
between two lysine residues.     
 
2.4.3 Hydrogen/deuterium exchange 
Although cross-linking mass spectrometry is a powerful tool for identifying the 
subunit interactions in protein complexes, the requirement for two adjacent lysine 
residues greatly limits its application.  To further reveal more subunit interactions, the 
assembly of the multi-protein complexes was addressed by measuring the rates of 
exchange of deuterium into the amide backbone from solvent.  Two proteins alone 
(PhnG and PhnH) and two protein complexes (PhnG2I2 and PhnG2H2I2J2K) were 
subjected to H/D exchange mass spectrometry analysis.  Protein PhnI, PhnJ and PhnK 
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are not used in this H/D exchange analysis because they are insoluble without a 
solubility tag.     
 
2.4.3.1 Subunit interaction of PhnG within the PhnG2I2 and PhnG2H2I2J2K complexes 
For PhnG alone, about 40% of the protein backbone undergoes deuterium 
exchange in a very short time (<10 s).  This result demonstrates that significant portions 
of PhnG alone are highly dynamic and likely to be largely unstructured (Figure 32).  The 
highly dynamic region of PhnG has apparently hindered previous crystallization efforts 
using PhnG alone.  The region with the most rapid H/D exchange rate (residues 28–67) 
is considered to be mostly unstructured or β-strands.  In the X-ray structure of 
PhnG2H2I2J2, residues 28-36 of PhnG are on a flexible loop (average B-factor 71 Å
2) 
while residue 37-70 of PhnG are on β-strands (average B-factor 30 Å2).   
Upon forming the PhnG2I2 complex, some highly dynamic regions of PhnG 
become more structured upon interaction with PhnI (Figure 32).  This is particularly true 
for the C-terminus region of PhnG and the portion of the protein that extends from Val-
47 through Leu-67.  Therefore, these two regions were proposed to be located at the 
interface between PhnG and PhnI in the PhnG2I2 complex.  The X-ray structure of 
PhnG2H2I2J2 complex revealed more details of the subunit interactions within these two 
regions of PhnG.  The protein sequence containing residues 47-67 forms a hydrophobic 
hairpin-like β-strand from PhnG that inserts into PhnI (Figure 33A).  The C-terminal 
region of PhnG, which forms an unstructured loop, interacts with the N-terminal loop of 
PhnI (Figure 33B).  However, further differences are not observed for PhnG within the 
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PhnG2H2I2J2K complex.  Considering the identification of a cross-linked bond between 
Lys-89 of PhnG and the N-terminus of PhnJ, there could be a small interface between 
PhnG and PhnJ.  In the crystal structure, the C-terminal region of PhnG interacts with 
PhnI and PhnJ simultaneously, which may explain the failure to identify a change in the 
H/D exchange level of PhnG upon forming a larger protein complex.  There could also 
be potential interactions between the N-terminal loop of PhnJ and Lys-89 with adjacent 
residues of PhnG if the N-terminal loop is subject to a conformational change to reduce 
the distance to PhnG (Figure 28).  PhnH is located about 30 Å away from PhnG so there 
are no interactions observed between these two subunits.  
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Figure 32: The differential deuterium exchange analysis of PhnG alone and PhnG within 
the PhnG2I2 or PhnG2H2I2J2K complexes.  The samples were incubated with D2O for 30 
minutes.  Different H/D exchange levels are labeled in different colors. The regions with 
H/D exchange levels higher than 45% are colored red.  The regions with H/D exchange 
levels from 30% to 45% are colored orange.  The regions with H/D exchange levels 
from 15% to 30% are colored yellow.  The regions with H/D exchange levels lower than 
15% are colored blue.  The regions without H/D exchange data are colored grey.  The 
region containing residues 47-67 and the C-terminal region are enclosed with a square.  
(A) PhnG alone.   (B) PhnG within PhnG2I2 or PhnG2H2I2J2K.    
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Figure 33: The interaction of PhnG with PhnI in the PhnG2H2I2J2 complex.  PhnG is 
colored green, PhnI is colored blue and other subunits of the PhnG2H2I2J2 complex are 
colored yellow.  (A) Residues 45-64 of PhnG interact with PhnI.  Residues 45-64 of 
PhnG are colored red.  (B) C-terminal region of PhnG interacts with PhnI.  C-terminal 
region is colored red.  
 
 113 
 
2.4.3.2 Subunit interactions of PhnI within the PhnG2I2 and PhnG2H2I2J2K complex 
Significant changes in the H/D exchange rates are observed for PhnI when the 
PhnG2I2 complex is compared with the PhnG2H2I2J2K complex.  In the X-ray structure, 
PhnJ is attached to the complex mainly through interactions with PhnI.  As a result, there 
is a dramatic change in the H/D exchange rates for PhnI upon the formation of the 
PhnG2H2I2J2K complex relative to the PhnG2I2 complex.  Similar structural transitions 
are often found in multi-protein complexes and in intrinsically disordered proteins that 
undergo synergistic folding in the presence of their binding partners (132, 133).  The 
interface between PhnI and PhnJ contains residues 81-86, 109-130 and the N-terminal 
region of PhnI.  As previously discussed, the N-terminal region of PhnI simultaneously 
interacts with both PhnG and PhnI in the PhnG2H2I2J2K complex.  The H/D exchange 
rate for this region was already very low in the PhnG2I2 complex.  It was not unexpected 
that a further change in the H/D exchange rate was not observed in PhnG2H2I2J2K 
complex.  There is a significant decrease in the H/D exchange rate observed for two 
other regions (residues 81-86 and residues 109-130) in the PhnG2H2I2J2K complex, as 
compared to the PhnG2I2 complex.  The interactions between these two regions and PhnJ 
are illustrated in Figure 34. Interestingly, region 109-130 is one of the most dynamic 
regions in the PhnG2I2 complex.  In the crystal structure, this region (residues 109 to 
130) is shown as a long unstructured loop (Figure 34B). 
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Figure 34: The regions containing residues 81-86 and 109-130 of PhnG interact with 
PhnJ. (A) The region containing residues 81-86 is colored red.  Other residues of PhnI 
are colored green.  PhnJ is colored blue.  (B) The region containing residues 109-130 is 
colored red.  Other residues of PhnI are colored green.  PhnJ is colored blue 
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2.4.3.3 Subunit interaction of PhnH within PhnG2H2I2J2K complex  
To further characterize the interaction between PhnH and the other subunits of 
PhnG2H2I2J2K complex, the differential deuterium exchange analysis of PhnH alone and 
PhnH within PhnG2H2I2J2K was conducted.  The peptides (
19RRLLKA24 and 
19RRLLKAMSEPGVI31) exchange at a much slower rate in the PhnG2H2I2J2K complex 
than in PhnH alone.  The regions containing residues from Ser-110 to Ala-121, from 
His-166 to Asp-173 and the C-terminal region from Pro-185 to Cys-194 become more 
protected in the complex.  PhnH alone forms a dimer in both solution and the crystal 
structure (61).  The dimer is assembled through the interactions between two N-terminal 
α-helices.  In the crystal structure of the PhnG2H2I2J2 complex, PhnH is attached to the 
complex through the interaction with PhnJ.  The interface between PhnH and PhnJ 
closely resembles that observed in the X-ray structure of the PhnH homodimer.  The 
dramatic decrease of the H/D exchange rate of all these region of PhnH, upon forming a 
complex, indicates that the interface between PhnH and PhnJ is larger and more compact 
in the complex than that between PhnH in the homodimer.   
 The crystal structure of the PhnG2H2I2J2 complex is consistent with this 
conclusion. All regions with significant H/D exchange differences between PhnH alone 
and PhnH within the complex are located at the interface between PhnH and PhnJ.  The 
region containing residues from Arg-19 to Ile-31 is located on an N-terminal α-helix of 
PhnH that interacts with another α-helix of PhnJ.  When compared with the N-terminal 
α-helices pair of the PhnH homodimer, the distance between these two α-helices is 
shorter in the complex (Figure 35), which indicates a more compact interaction between 
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PhnH and PhnJ.  The PhnH regions from Ser-110 to Ala-121 and from His-166 to Asp-
173 are located on two separate unstructured loops that interact with a short α-helix of 
PhnJ (Figure 36).  However, similar interactions of these two regions are not observed in 
the PhnH homodimer.  Part of the C-terminal region of PhnH interacts with the end of 
the N-terminal α-helix of PhnJ or the other PhnH monomer in the PhnG2H2I2J2 complex 
or PhnH homodimer, respectively.  The distance between the C-terminal loop of PhnH 
and the N-terminal α-helix of the interacting subunit is around 3 Å shorter in the 
PhnG2H2I2J2 complex than that in PhnH homodimer (Figure 37).  These interactions 
suggest that the interface between PhnH and PhnJ is larger and more compact than that 
in PhnH homodimer.     
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Figure 35: The interaction between two N-terminal α-helices at the interface in 
PhnG2H2I2J2 complex and PhnH homodimer.  (A) The interface between PhnH and PhnJ 
in PhnG2H2I2J2 complex.  PhnH and PhnJ are colored green and blue, respectively.  The 
distance, 5.9 Å, is measured between two α-carbons of Ser-26 of PhnH and Val-28 of 
PhnJ.  (B) The interface of the PhnH homodimer. One PhnH monomer is colored green 
and the other one is colored blue. The distance, 7.9 Å, is measured between two α-
carbons of Ser-26 of both monomers.  
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Figure 36: The regions containing residues 110-121 and residues 166-173 of PhnH 
interact with the other PhnH monomer or PhnJ in the PhnH homodimer and the 
PhnG2H2I2J2 complex, respectively.  (A) PhnH homodimer.  The region containing 
residues 166-173 is colored red.  The region containing residues 110-121 is not included 
in the crystal structure of the PhnH homodimer. Other residues of this monomer are 
colored green. The other monomer in PhnH homodimer is colored blue.  (B) 
PhnG2H2I2J2 complex.  PhnH and PhnJ are colored green and blue, respectively.  The 
regions containing residues 110-121 and residues 166-173 of PhnH are colored red.      
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Figure 37: The C-terminal regions of PhnH interact with the other PhnH monomer or 
PhnJ in the PhnH the homodimer and the PhnG2H2I2J2 complex.  (A) PhnG2H2I2J2 
complex.  PhnH and PhnJ are colored green and blue, respectively.  The C-terminal 
region of PhnH is colored red.  The distance, 6.3 Å, is measured between the α-carbons 
of Arg-187 of PhnH and Ala-29 of PhnJ.  (B) PhnH homodimer.  C-terminal region of 
PhnH is colored red.  Other residues of this monomer are colored green. The other 
monomer in PhnH homodimer is colored blue.  The distance, 9.5 Å, is measured 
between the α-carbons of Arg-187 of one PhnH monomer and the α-carbons of Ser-26 of 
the other PhnH monomer.  
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2.4.4 Low resolution structural model 
The results obtained from the mass spectrometry and chemical cross-linking 
experiments were used to propose a low-resolution model for the assembly of the C–P 
lyase complex (Scheme 11).   In the crystal structure of PhnG2H2I2J2, the C–P lyase core 
complex resembles the letter ‘H’ with rounded arms that are twisted approximately 45° 
in and out of the plane with respect to each other (127).  The arms are composed on 
opposing sides by the two PhnG molecules and on the other sides by tight complexes 
between PhnJ and PhnH, which confirmed the interactions between PhnJ and PhnG 
(Figure 38) (127).  At the center of the molecule, a compact PhnI homodimer forms a 
disc-like structure that serves as a central hub for attachment of the other subunits, which 
agrees with the PhnG2I2 core in the low resolution structural model.  At the C- and N-
termini there are helical extensions of the core domain of PhnI, approximately 35 
residues that grasp PhnJ and tether it to the complex via extensive interactions, which is 
consistent with the identified interactions between PhnI and PhnJ.  In turn, PhnJ attaches 
PhnH to the complex through packing of conserved α-helices in both proteins, which 
matches the fragment of PhnHJ in MS/MS spectrum.  
The closest sequence homologues for PhnG, PhnI, and PhnJ were found to be the 
putative Trp repressor protein (PDB id: 3KOR), carboxymethyl-2-hydroxymuconate 
semialdehyde dehydrogenase (PDB id: 2D4E), and PhnH (PDB id: 2FSU), respectively.  
However, the sequence identities of these proteins to their closest identified homologues 
are less than 20%, and so a reliable homology model could not be built for any of these 
proteins.  It was quite interesting that the closest structural model for PhnJ is PhnH.  In 
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the X-ray structure of PhnG2H2I2J2, the core folds of PhnJ and PhnH are nearly identical. 
Moreover, the interface between PhnH and PhnJ closely resemble that observed in the 
previously published X-ray structure of the PhnH homodimer (Figure 39).  
 
 
 
 
 
 
Scheme 16: Low resolution assembly model for C-P lyase complex 
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Figure 38: (A) Overall structure of the 240 kDa C–P lyase core complex. (B) Schematic 
architecture of the complex with structural domains indicated (127). 
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A 
 
B 
 
 
Figure 39: The interface between PhnH and PhnJ closely resembles the PhnH 
homodimer. (A) The interface between PhnH and PhnJ in the PhnG2H2I2J2 complex. The 
interacting α-helices of PhnH and PhnJ are colored red and purple, respectively.  PhnH is 
colored green and PhnJ is colored blue.  (B) The interface of the PhnH homodimer. The 
interacting α-helices of both PhnH monomer are colored red.   
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2.4.5 Cryo-electron microscopy structural model 
We have demonstrated a unique binding mode of the NBD-like PhnK to the C-P 
lyase core complex, PhnG2H2I2J2.  Even though there exist two identical binding sites for 
PhnK within the core complex, only one PhnK can bind at a time, leading to a more 
exposed proposed active site residue Gly32 from PhnJ on the PhnK bound side (Figure 
40).  The proposed glycyl radical formed at Gly32 was postulated to abstract the 
hydrogen of Cys272 to form a thiyl radical during PhnJ catalysis (53).  Such 
rearrangement around the active site may facilitate the delivery of the substrate or 
release of the reaction product. 
However, Seweryn et al made the discovery that Gly32 of PhnJ is more than 30 
Å away from Cys272 in the crystal structure of the PhnG2H2I2J2 complex.  In our cryo-
EM structure of PhnG2H2I2J2 with PhnK bound, the overall structure of PhnJ remains 
similar to the crystal structure with Gly32 still ∼30 Å away from Cys272.  If the 
proposed reaction mechanism for C-P lyase, which involves the direct interaction 
between Cys272 and Gly32, is correct, then substantial structural rearrangements must 
occur transiently and/or after the binding of substrates or other protein subunits to this 
complex.  
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Figure 40: Binding of PhnK to the PhnG2H2I2J2 complex causes Gly32 of PhnJ to 
become more exposed (A) On the side of the complex without PhnK bound (apo side), 
helix 5 of PhnJ interacts with PhnH.  (B) On the side with PhnK bound (bound side), the 
densities for helix 5 and helix 6 of PhnJ move away from PhnH to more fully expose 
Gly32 from PhnJ.  The density map of PhnG2H2I2J2K is rendered at 4.5 σ above the 
mean and colored coded as follows, yellow: PhnG, blue: PhnH, green: PhnJ, orange: 
PhnI, lavender: PhnK.  The red sphere in the model denotes Gly32 from PhnJ.  Inset 
shows the map of the PhnG2H2I2J2K complex in the same orientation as Figure 18E with 
the locations of (A) and (B) labeled. 
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PhnK has all of the structural motifs to bind ATP.  These interactions may help 
recruit ATP as the substrate for the C-P lyase reaction.  While the two-fold symmetrical 
C-P lyase core complex PhnG2H2I2J2 potentially provides two equivalent sets of active 
sites for two series of reactions, the loose and monomeric binding of PhnK suggests that 
this subunit may alternate between the two binding sites on the core complex to deliver 
ATP and facilitate the series of reactions in a staggered time frame.  Further biochemical 
and structural studies are needed to test these hypotheses. The structural information 
provided here may provide a better understanding of the enzymatic reaction mechanism 
for phosphonate utilization, especially the function of the NBD-like PhnK.  These results 
clearly demonstrate the power of cryo-EM for the structural analysis of small (∼200 
kDa) asymmetrical multi-subunit protein complexes with compositional heterogeneity. 
In summary, we have used high-resolution mass spectrometry, chemical cross-
linking, hydrogen/deuterium exchange, analytical ultracentrifugation, N-terminal protein 
sequencing and cryo-electron microscopy to characterize the stoichiometry, revealed 
subunits interactions and construct structural models for the PhnG2H2I2J2 and 
PhnG2H2I2J2K C–P lyase complexes from E. coli.  The interactions between the 
monomeric PhnK and the dimeric PhnG2H2I2J2 complex was revealed.  The proposed 
stoichiometry, subunit interaction and low resolution structural model of PhnG2H2I2J2 
complex agreed quite well with the crystal structure that was published later.   
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2.4.6 Future perspectives  
Based on previous genetic and biochemical studies, seven proteins are essential 
for the cleavage of the C-P bond.  Five out of these seven proteins are able to form 
multi-subunit complexes, PhnG2I2, PhnG2H2I2J2 and PhnG2H2I2J2K.  The determination 
of the high resolution structural model of PhnG2H2I2J2K and PhnG2H2I2J2 protein 
complex provides a basis for the greater understanding of the physiological functions of 
these complexes.  However, as essential proteins in the proposed pathway for the 
hydrolysis of C-P bonds, PhnL and PhnM are not components in the structurally 
determined C-P lyase complexes.  The marginal solubility of these two proteins in vitro 
implies that other proteins including PhnL and PhnM may form a larger protein complex 
to cleave the C-P bond.  It is known that PhnL can work with the subunits PhnG, PhnH, 
PhnI to catalyze the initial reaction within the C-P lyase pathway.  However, the specific 
role of each protein is unknown.  It is possible that each protein has an active site 
performing a distinct step of the initial reaction. An alternative explanation is that only 
some of the subunits have catalytic functions while others are responsible for scaffold 
and regulatory roles.  The elucidation of the structure of the C-P lyase protein complex 
with substrates, inhibitors and cofactors bound to the active sites will be helpful to shed 
light on these questions.  
Despite attempts to reconstitute the C-P lyase complexes catalyzed reactions in 
vitro, the purified C-P lyase complexes are still catalytically incompetent.  It may require 
additional subunits or factors to activate these complexes.  Further genetic and 
biochemical studies such as protein-protein interaction profiling and mass spectrometry 
 128 
 
based metabolomics will provide powerful tools to find the critical missing part of the C-
P lyase protein complex.  PhnJ, a core subunit of PhnG2H2I2J2 or PhnG2H2I2J2K 
complex, is apparently responsible for cleavage of the C-P bond.  Based on the proposed 
reaction mechanism of PhnJ, a reduced Fe-S cluster cleaves S-Adenosyl methionine to 
generate a 5’-deoxyadenosyl radical intermediate.  A hydrogen atom on Gly-32 is then 
abstracted by the radical intermediate to form a glycyl radical.  The radical then transfers 
from Gly-32 to Cys-272 generating a thiyl radical capable of cleaving the C-P bond of 
PRPn (45).  The participation of Gly32 in the radical transferring process was confirmed 
by deuterium labeled mass spectrometry.  However, Gly32 is 30 Å away from Cys-252 
and the proposed Fe-S cluster, which implies that PhnJ must go through a dramatic 
conformational change during the catalytic cycle or there are other unidentified steps in 
the radical transferring process.  Further studies including fluorescence resonance energy 
transfer (FRET) analysis and the elucidation of the crystal structure of the complex 
bound with Fe-S clusters will be helpful to answer these issues.  
 
 
 
 
 
 
 
 
 129 
 
CHAPTER III 
 
MECHANISTIC CHARACTERIZATION OF THE PHOSPHOTRIESTERASE FROM 
SPHINGOBIUM SP. STRAIN TCM1* 
 
3.1   Introduction 
 
Phosphotriesters are a group of organophosphates that were initially developed 
during World War II.  This group of compounds was first utilized as insecticides for 
crop protection (63).  The structure of this group of compounds is a phosphate center 
with three ester linked functional groups.  In recent years, a related group of 
organophosphotriesters has gained popularity for use as plasticizers and flame retardants 
in lubricants, durable plastics, and foams (65, 66).  Compounds such as tris(2-
chloroethyl) phosphate (compound 5 in Scheme 12) (65) and triphenyl phosphate (66) 
do not contain a labile ester bond but rather make use of the stable nature of these 
compounds to inhibit combustion and improve the performance of other organic 
                                                 
* Part of this chapter is reprinted with permission from “Interrogation of the Substrate Profile and Catalytic 
Properties of the Phosphotriesterase from Sphingobium sp. Strain TCM1: An Enzyme Capable of 
Hydrolyzing Organophosphate Flame Retardants and Plasticizers” by Dao Feng Xiang, Andrew N. Bigley, 
Zhongjie Ren, Haoran Xue, Kenneth G. Hull, Daniel Romo, and Frank M. Raushel, Biochemistry 2015 54 
(51), 7539-7549, Copyright 2016 by American Chemical Society.   
 
Part of this chapter is reprinted with permission from “Chemical Mechanism of the Phosphotriesterase 
from Sphingobium sp. Strain TCM1, an Enzyme Capable of Hydrolyzing Organophosphate Flame 
Retardants” by Andrew N. Bigley, Dao Feng Xiang, Zhongjie Ren, Haoran Xue, Kenneth G. Hull, Daniel 
Romo, and Frank M. Raushel, Journal of the American Chemical Society 2016 138 (9), 2921-2924, 
Copyright 2016 by American Chemical Society.  
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compounds.  While not neurotoxins, many of the flame retardants contain halogenated 
alkyl or aromatic esters and are known, or suspected, chemical carcinogens (66).  The 
contamination of the environment by organophosphorus flame retardants has become 
widespread, and these compounds are now considered to be major emerging pollutants 
(3). 
In various species of bacteria, natural and synthetic organophosphotriesters are 
hydrolyzed by phosphotriesterase (PTE) (68-71). To utilize the man-made 
organophosphotriesters as phosphorus source in the environment, bacteria evolved the 
ability to hydrolyze this type of compounds.  The structural similarity of the phosphoryl 
centers between synthetic and natural substrates may play an essential role for the 
development of the promiscuous activity towards synthetic organophosphortriesters (72).  
Due to the lack of a sufficiently labile leaving group, currently identified 
phosphotriesterases have little or no activity against organophosphorus flame retardants 
and plasticizers (88, 102-104). Two novel phosphotriesterase-like enzymes from 
Sphingomonas sp. strain TDK1 (Sm-PTE) and Sphingobium sp. strain TCM1 (Sb-PTE) 
have recently been reported to hydrolyze organophosphates that are not substrates for 
other phosphotriesterases, such as Pd-PTE or OpdA (103).  When this study was 
initiated, very little was known about these enzymes aside from their amino acid 
sequence and their dependence on the addition of divalent metal ions for catalytic 
activity.  In addition, there was no structural or mechanistic information available for 
either Sm-PTE or Sb-PTE, or any close homologue of known function.  
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Due to the lack of a sufficiently labile leaving group, currently identified 
phosphotriesterases have little or no activity against organophosphorus flame retardants 
and plasticizers (88, 102-104). Two novel phosphotriesterase-like enzymes from 
Sphingomonas sp. strain TDK1 (Sm-PTE) and Sphingobium sp. strain TCM1 (Sb-PTE) 
have recently been reported to hydrolyze organophosphates that are not substrates for 
other phosphotriesterases, such as Pd-PTE or OpdA (103).  When this study was 
initiated, very little was known about these enzymes aside from their amino acid 
sequence and their dependence on the addition of divalent metal ions for catalytic 
activity.  In addition, there was no structural or mechanistic information available for 
either Sm-PTE or Sb-PTE, or any close homologue of known function.  
Structural models of PTEs from various species reveal different protein folding 
patterns of PTEs including TIM-barrel, β-lactamase, “pita-bread”, and β-propeller folds 
(73-77).  Despite the varied protein structural folds, PTEs are known to possess divalent 
metal center(s) to bind and activate substrates for hydrolysis (71, 74, 78, 79).  PTEs with 
different folding patterns hydrolyze the organophosphotriesters via different chemical 
mechanisms.   
Due to the lack of a sufficiently labile leaving group, currently identified 
phosphotriesterases have little or no activity against organophosphorus flame retardants 
and plasticizers (88, 102-104). Two novel phosphotriesterase-like enzymes from 
Sphingomonas sp. strain TDK1 (Sm-PTE) and Sphingobium sp. strain TCM1 (Sb-PTE) 
have recently been reported to hydrolyze organophosphates that are not substrates for 
other phosphotriesterases, such as Pd-PTE or OpdA (103).  When this study was 
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initiated, very little was known about these enzymes aside from their amino acid 
sequence and their dependence on the addition of divalent metal ions for catalytic 
activity.  In addition, there was no structural or mechanistic information available for 
either Sm-PTE or Sb-PTE, or any close homologue of known function.  
 
3.2   Materials and Methods  
 
3.2.1 Materials  
Unless otherwise noted, the bacterial growth medium was obtained from 
Research Products International and general chemicals were purchased from 
Sigma/Aldrich.  Paraoxon is synthesized as previously reported (96).  The C18 reverse 
phase column was purchased from Waters Corporation.  O18 labeled water was obtained 
from Cambridge Isotope Laboratories. Protein Sb-PTE was expressed and purified by 
Dr. Dao Feng Xiang.    
 
3.2.2 Inactivation of Sb-PTE by 1-butynyl dibutylphosphate 
All substrate profile, kinetic parameters and optimal metal determination of Sb-
PTE were determined by Dr. Dao Feng Xiang.  To assess the interaction of Sb-PTE with 
1-butynyl dibutylphosphate, the enzyme (32 nM) was mixed with this compound in 
various molar ratios ranging from 0 to 37.5 in 50 mM CHES buffer (pH 9.0).  The 
residual catalytic activity of Sb-PTE was assayed using 0.40 mM paraoxon as the 
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substrate.  Samples of the fully inhibited enzyme were subjected to MS analysis to 
determine the number of modifications on the intact protein in the presence of excess 
inhibitor.  For reactivation studies, 500 μL samples of the inhibited enzyme were 
prepared by mixing 1.3 μM enzyme with 30 μM 1-butynyl dibutylphosphate in 50 mM 
HEPES (pH 7.0).  The enzyme was fully inhibited within 10 minutes.  Reactivation of 
the inhibited enzyme was tested by diluting samples 1:2 into a reactivation mixture 
containing 50 mM CHES (pH 9.0) and hydroxylamine (0–20 mM). The reactivation of 
catalytic activity was followed over time by measuring the enzymatic activity using 0.60 
mM paraoxon as the substrate.  Reactivation of Sb-PTE was also examined, in the 
absence of added hydroxylamine, by variation of the pH from 7 to 10. 
 
3.2.3 MS/MS analysis of inactivated Sb-PTE 
Samples of Sb-PTE, which had been inactivated by 1-butynyl dibutylphosphate, 
and a control sample were loaded on SDS–PAGE gels at a concentration of 1.5 mg/mL 
and visualized by Coomassie Blue staining.  The samples were proteolyzed via the 
addition of trypsin using a previously described protocol (134).  The samples were 
analyzed by LC–MS (Dionex nanoRSLC and an Orbitrap Fusion Tribrid Mass 
Spectrometer from Thermo Scientific).  Briefly, 1.0 μL of the digested protein sample 
was loaded onto a 75 μm × 15 cm Acclaim Pepmap C18 column and eluted over 30 
minutes with a total run time of 1 hour.  The eluted peptides were introduced into the 
mass spectrometer and analyzed using the Orbitrap (OT) mass spectrometer in positive 
ion mode with the following settings: resolution, 120 K; scan range, m/z 200–1800; 
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maximal injection time, 50 ms; AGC target, 2 × 104; S-lens RF level, 60.  Charge states 
ranging from 2 to 7 were accepted, and targeting ions were excluded for 60 s.  MS/MS 
data were obtained using the HCD cell, and fragment masses were determined using the 
OT mass spectrometer at a resolution of 30 K.  The data were analyzed using PEAKS 
Studio Software (Thermo Scientific).  For the analysis of peptide MS and MS/MS from 
the inhibitor modification experiments, maximal mass deviations of 10 ppm for MS and 
0.5 D for MS/MS were accepted.  Additionally, carbamidomethylation of cysteine was 
taken into account as a fixed modification, and oxidation of methionine was set as a 
varied modification.  Up to three missed cleavage sites were utilized during data 
processing. 
 
3.2.4 18O-labeling of Sb-PTE protein   
50 μL samples of 220 μM Sb-PTE were dried in-vacuo at room temperature. 
Similarly, samples of 20 μL 0.5 M CHES (pH 9) and, separately, 66 μL of 8.4 mM 
paraoxon were dried to completion. Samples were then reconstituted and combined in a 
total of 120 μL of 18O labeled or unlabeled water as a control.  The samples were 
incubated at room temperature until the hydrolysis of the paraoxon was complete (~2 
hr).  The protein was run on SDS-PAGE gel and the appropriate bands were digested in-
gel with trypsin prior to MS analysis as previously described (54).  
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3.2.5 18O-labeling of reaction products by Sb-PTE  
18O incorporation into the reaction products of Sb-PTE were tested under single 
and multi-turnover conditions.  100 μL reactions were in conducted in 60% 18O labeled 
water with 20 mM NH4HCO3 (pH 9.0).  For single turnover conditions 50 μM paraoxon 
was used with 150 μM Sb-PTE.  For multiple turnover conditions, 500 μM paraoxon was 
used with 50 μM Sb-PTE.  Reactions were run overnight and the protein filtered using a 
Viaspin 500 centrifugal filtration device (GE Healthcare).  Reaction products were 
analyzed by mass spectrometry using a Thermo Scientific Q Exactive mass 
spectrometer.  The samples were applied to the mass spectrometer by direct injection at a 
flow rate of 200 μL/min. A blank solution of ammonium bicarbonate was utilized 
between each sample to avoid peak carry-over between runs.  The mass spectrometer 
was calibrated using a Pierce™ Negative Ion Calibration Solution from Thermo 
Scientific, USA. The results were analyzed using software Xcalibur (Thermo Scientific). 
 
3.3   Results 
 
3.3.1 Inactivation of Sb-phosphotriesterase 
1-butynyl dibutylphosphate was synthesized and tested as a mechanism-based 
inactivator of Sb-PTE.  The enzymatic hydrolysis of this compound is expected to 
generate a highly reactive ketene intermediate, which can potentially react with available 
nucleophiles in the active site as illustrated in Scheme 17.  The alkynyl phosphate ester 
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was found to be a highly effective inhibitor of Sb-PTE with nearly complete inhibition 
achieved with near stoichiometric amounts of inhibitor (Figure 41).  The mass spectrum 
of the modified protein exhibited two major additional peaks that are shifted by ∼71 and 
∼142 Da, relative to the unlabeled protein, and two minor peaks.  This result is 
consistent with the addition of up to four ketene groups to the protein (Figure 42B).  
Reactivation of the enzyme by the addition of hydroxylamine and changes in pH 
were attempted.  Incubation of the inhibited enzyme with 5.0 mM hydroxylamine was 
found to restore approximately 60% of the enzymatic activity in 3 h, and >90% of the 
original catalytic activity was restored after 24 h.  A similar reactivation profile occurs 
after incubation of the inhibited enzyme at pH 10 (data not shown).  Analysis of the 
MS/MS spectra of the inhibited protein identified residues Tyr-219, Ser-474, Tyr-456, 
and Ser-458 as being modified by the mechanism-based inactivator (Figure 43).  
The addition of the substrate reduced the rate of inactivation of Sb-PTE by the 
suicide substrate.  The ability of the substrate to protect the enzymatic activity was tested 
by changing the order of addition of the substrate and inhibitor in reaction mixtures 
containing 50 mM CHES (pH 9.0) at 30 °C with 2.0 mM paraoxon as the substrate.  The 
addition of paraoxon to a premixture of Sb-PTE (10 nM) and 1-butynyl dibutylphosphate 
(20 nM) resulted in a reaction rate that was 13% of the uninhibited control reaction rate.  
The addition of 1-butynyl dibutylphosphate (20 nM) to a premixture of Sb-PTE (10 nM) 
and the substrate paraoxon (2.0 mM) gave a reaction rate that was 62% of the 
uninhibited control reaction rate.  These data demonstrated that the substrate paraoxon 
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can protect Sb-PTE against inactivation by the suicide substrate 1-butynyl 
dibutylphosphate.  
 
 
 
 
Scheme 17: Covalent modification of TCM1 by 1-butynyl dibutylphosphate 
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Figure 41: Inactivation of Sb-PTE by 1-butynyl dibutylphosphate.  Various amounts of 
the mechanism-based inactivator were added to 32 nM Sb-PTE in CHES buffer (pH 9.0).  
Aliquots were removed after 10 minutes and tested for catalytic activity using 0.40 mM 
paraoxon at pH 9.0.  The inset shows the reactivation of enzyme activity after the 
addition of hydroxylamine [(●) 0, (■) 1.0, and (◆) 5.0 mM] at pH 7.0.  The activity of 
the rescued enzyme was assayed with 0.6 mM paraoxon in 50 mM CHES (pH 9.0).   
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Figure 42: MS of (A) intact Sb-PTE and (B) 1-butynyl dibutylphosphate-inactivated Sb-
PTE.  Masses of major species are listed with the labeled protein showing addition of up 
to four butyl groups.  
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Figure 43: MS/MS of the peptide from residue Leu-469 to Arg-483 of Sb-PTE.  The top 
panel shows the spectrum for the unmodified protein, while the bottom panel shows the 
protein after inactivation by 1-butynyl dibutylphosphate.  Modification is identified at 
Ser-474 (peak y10).  Masses for peaks y9–y11 are provided in the plot.  
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3.3.2 18O-labeling of Sb-PTE protein and its reaction products by Sb-PTE   
Peptide coverage for the control reaction was 85% while coverage for the 18O 
experiment was 87% (Table 4).  In both cases the peptide containing the proposed active 
site aspartate (Asp-478) was observed.  No peptide was identified that had an M+2 or 
M+4 peak that differed significantly from that of the unlabeled control experiment.  The 
only peptides containing either glutamate or aspartate that were not identified by mass 
spectrometry were 181DPR183,373SQPKMRLVGEAK384, and 499IVDLR503.  
When the hydrolysis reaction was conducted in unlabeled water the p-
nitrophenolate was isolated with an m/z of 138 and diethyl phosphate at an m/z of 153 
(Figure 44a).  However, when the hydrolysis reaction was conducted under multiple 
turnover conditions in ∼60% 18O-labeled water, the p-nitrophenolate was produced with 
an m/z of 138, whereas the diethyl phosphate was isolated as a mixture of species 
with m/z values of 153 and 155 (Figure 44b).  When we utilized a 3-fold molar excess 
of Sb-PTE to hydrolyze paraoxon in ∼60% 18O-labeled water, the isotopic content of the 
recovered diethyl phosphate was essentially the same as the solvent (Figure 44c).   
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Table 4: Predicted and observed masses for peptides found from Sb-PTE. 
 
Peptide Predicted 
Mass 
Observed 
Mass 16O 
Observed Mass 18O 
88-
QVVIGPGDRPETGLQGQTTIE
DVVSGRS-114 
2808.44 2808.44 2808.44 
125-RLVGRTDIWNRG-134 1229.68 1229.67 1229.67 
129-RTDIWNRG-134 804.39 804.39 804.40 
135-
RGGNLQLSWVDQC(Carbamid
omethyl)AYVSTFKQ-153 
2173.02 2173.04 2173.03 
154-KQAGPITANSRS-163 1014.52 1014.53 NO 
164-RSALFLRE-169 706.42 706.42 706.42 
170-REPAGVAVIDVRD-180 1125.62 1125.62 1125.62 
184-RAPKPVRL-189 667.42 667.42 667.42 
190-RLLRD-192 401.28 NO 401.28 
193-
RDRGSIDAVETMHAIAAPGR
K-211 
1966.97 1966.97 1966.98 
 143 
 
Table 4 (Continued) 
Peptide Predicted 
Mass 
Observed 
Mass 16O 
Observed Mass 18O 
195-
RGSIDAVETMHAIAAPGRKV-
212 
1823.95 1823.94 NO 
227-
RGEEDAAWLSIYDASNC(Carb
amidomethyl)LNPKL-246 
2253.00 2253.01 2253.01 
247-KLQSEFKW-252 751.39 751.39 751.39 
268-RRVYGTEVVPGLGSGKG-
282 
1518.81 1518.82 NO 
269-RVYGTEVVPGLGSGKG-
282 
1362.72 1362.72 1362.72 
283-KGGLHVLDISDMKR-294 1284.65 1284.66 1284.66 
298-RYLGRF-301 508.28 508.28 508.28 
302-
RFGVTRPNGLTAGFTPHEVSI
SHDERR-326 
 
2724.34 2724.34 2724.34 
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Table 4 (Continued) 
Peptide Predicted 
Mass 
Observed 
Mass 16O 
Observed Mass 18O 
385-
KQGGFHSVVPASINGVPHLV
GAAELGAC(Carbamidomethyl)
PGTWPRI-417 
3338.66 3338.68 3338.68 
418-RIINIADEKN-425 915.51 915.51 915.51 
429-KIVGEFKL-434 692.39 692.39 692.39 
435-KLQMNIKE-440 746.42 746.42 746.42 
441-
KENC(Carbamidomethyl)DAIRF
-447 
877.38 877.38 877.38 
448-RFTPRK-451 520.28 520.28 520.28 
452-RKEDPYASFIPIPDITARL-
468 
1932.99 1933.00 1933.00 
469-
RLGAVGSHFNDVDDARN-483 
1572.74 1572.74 1572.74 
487-RLGLFPFFAGGVRI-498 1280.71 1280.71 1280.71 
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Table 4 (Continued) 
Peptide Predicted 
Mass 
Observed 
Mass 16O 
Observed Mass 18O 
504-
RDPTKPVEVGYYKPGANPDT
PLSGNGLNWTGLNDQVTDGC
(Carbamidomethyl)MSHVRY-
547 
4757.21 4757.23 4757.23 
548-
RYVPESGHIWFAC(Carbamido
methyl)VTTGFHVVELNPDLRA
-574 
3143.53 3143.54 3143.54 
577-RLGFPTVKL-583 761.45 761.45 761.45 
584-KLEHHHHHH-591 1083.50 1083.49 1083.49 
M+2 Peptides observed 
441-
KENC(Carbamidomethyl)DAIRF
TPR-451 
1380.65 1380.65 NO 
453-
KEDPYASFIPIPDITARLGAVG
SHFNDVDDAR-483 
3360.63 3360.63 3360.63 
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Figure 44: Mass spectra of p-nitrophenol and diethlyphosphate from the Sb-PTE 
catalyzed hydrolysis of paraoxon.  (a) Control reaction conducted in unlabeled water.  
(b) Multiple turnover conditions where 500 μM paraoxon was hydrolyzed with 50 
μM Sb-PTE in ∼60% 18O-labeled water.  (c) Single turnover conditions in ∼60% 18O-
labeled water where 50 μM paraoxon was hydrolyzed with 150 μM Sb-PTE.  The peaks 
identified are unlabeled p-nitrophenolate (m/z = 138.02), unlabeled diethylphosphate 
(m/z = 153.03), and 18O-labeled diethylphosphate (m/z = 155.03).  
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3.4   Discussion 
 
3.4.1 X-ray crystal structure of Sb-PTE 
The X-ray crystal structure of Sb-PTE has been recently reported, revealing a 
seven-bladed β-propeller protein fold (Figure 45A) (135). This enzyme appears as a 
homodimer in the crystal structure (Figure 46A).  A binuclear manganese center is 
located within the active site of Sb-PTE (135).  These two metal ions are bridged by Glu-
201 and a water molecule. The α manganese ion is further liganded to the protein by the 
side chain groups of His-389, His-475, and Glu-407 and the β manganese ion is 
coordinated to His-317 and His-258 (Figure 45B) (135).  
 
3.4.2 Covalent modification of active site residues 
The inhibitor 1-butynyl dibutylphosphate proved to be an incredibly potent 
inhibitor of Sb-PTE.  Full inhibition was observed with approximately 2 equiv of 
inhibitor.  By contrast, Pd-PTE was reported to hydrolyze ∼500 molecules of a similar 
mechanism-based inhibitor before being fully inactivated (136).  The ability to 
reactivate Sb-PTE with hydroxylamine following inactivation with 1-butynyl 
dibutylphosphate suggests the loss of catalytic activity is most likely due to the 
modification of one or more histidine residues (136).  However, MS/MS analysis 
identified two serine residues (Ser-458 and Ser-474) and two tyrosine residues (Tyr-219 
and Tyr-456) as being labeled.  Mutation of Tyr-219, Ser-458, and Tyr-456 residues did 
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not result in substantial loss of catalytic activity or metal binding (137).  Mutation of 
Ser-474, which appears to be adjacent to His-475 (the proposed active site base), did 
severely diminish the activity of Sb-PTE.  In the X-ray structure of Sb-PTE, two 
identified residues (Ser-474 and Tyr-219) are located adjacent to the active site. The 
distance from the α-Mn2+ ion at the active site to these two residues is shorter than 12 Å 
(Figure 47A).  The reactive product from the hydrolysis of 1-butynyl dibutylphosphate 
could migrate within the active site to modify surrounding nucleophilic residues.  Two 
other residues (Tyr-456 and Ser-458) are located in a short hydrophobic loop spanning 
residues 447-463, far away from the active site.  However, in the crystal structure of the 
Sb-PTE dimer, this loop is extended into the active site of the other subunit, precluding 
phosphotriester binding to the active site (Figure 46B).  The distance from Tyr-456 and 
Ser-458 to the α-Mn2+ ion at the active site of the other subunit is 5.8 Å and 16.7 Å, 
respectively (Figure 47B).  In addition, the loop containing these two residues is flexible. 
The average B-factor of this loop is 50 Å2 while the average B-factor of the whole 
protein is 39 Å2. This loop could be subject to a conformational change to reduce the 
distance between Ser-458 and the active site to facilitate the modification.  The observed 
modification of Tyr-456 and Ser-458 suggests that Sb-PTE may catalyze the reaction in 
solution as a dimer.  In the catalytic process, the loop containing these two residues 
could undergo a conformational changes to control the uptake of substrates and the 
release of products.   
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Figure 45: Crystal structure of Sb-PTE (PDB id: 5HRM).  Manganese ions at the active 
site are shown in purple.  (A) Top down view of Sb-PTE showing the seven bladed β-
propeller structure.  (B) Metal center ligation of Sb-PTE. 
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Figure 46: The crystal structure of the Sb-PTE dimer.  (A) Two subunits of Sb-PTE 
dimer are colored green and blue. The binuclear manganese ions are colored purple in 
the center of each monomer.  (B) The hydrophobic loop (residues 447-463) extending 
into the active site of the other subunit is colored red.   
 151 
 
 
 
Figure 47: The distance between the active site and four modified residues in the crystal 
structure of Sb-PTE.  (A) The distance between Tyr-219 and the α-Mn2+ ion is 6.2 Å; the 
distance between Ser-474 and the α-Mn2+ ion is 10.6 Å.  (B) The distance between Tyr-
456 and the α-Mn2+ ion is 5.8 Å; the distance between Ser-458 and the α-Mn2+ ion is 
16.7 Å. 
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3.4.3 Proposed chemical mechanism 
As a phosphotriesterase with a β-propeller fold, the structure of Sb-PTE shows 
significant differences with other members in this group of enzymes such as DFPase and 
PON1. Compared with these two enzymes that have a six-bladed β-propeller fold, Sb-
PTE adopts a seven-bladed β-propeller fold.  Instead of a single calcium at the active 
site, Sb-PTE contains a binuclear metal center located in its active site.  It is quite 
surprising that the structure of the binuclear metal center in Sb-PTE is quite similar with 
that in Pd-PTE, which adopts a typical TIM barrel fold. The chemical mechanism of the 
phosphotriester hydrolysis is quite different between phosphotriesterases with β-
propeller fold and TIM barrel fold.  The enzymes with a β-propeller fold are proposed to 
go through a covalent reaction intermediate, while the TIM-barrel enzymes usually 
hydrolyze the substrate by direct attack of water (83).   
There are a variety of reaction mechanisms that are possible for Sb-PTE 
catalyzed hydrolysis of organophosphatetriesters.  The most straightforward mechanism 
utilizes the direct nucleophilic attack of an activated water/hydroxide on the phosphorus 
center (Scheme 18a).  For substrates with highly activated leaving groups, such as p-
nitrophenol, it is also possible for the initial nucleophilic attack to occur on the aromatic 
ring of the leaving group with subsequent C–O bond cleavage through a nucleophilic 
aromatic substitution mechanism, rather than breakage of the P–O bond (Scheme 18b).  
Alternatively, the reaction may be initiated by an enzyme-based nucleophile that results 
in the formation of a covalent intermediate that is subsequently hydrolyzed by an 
activated water/hydroxide (Scheme 18c).  If the enzyme-based nucleophile is the side 
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chain carboxylate from either glutamate or aspartate, then hydrolysis of the covalent 
intermediate can occur either by nucleophilic attack at phosphorus or attack on the 
carboxylate carbon proceeding through a typical tetrahedral intermediate (Scheme 18d).   
To determine whether the initial nucleophilic attack is directed at the leaving 
group with C–O bond cleavage (Scheme 18b), Sb-PTE was used to catalyze the 
hydrolysis of paraoxon (diethyl p-nitrophenyl phosphate) in 18O-labeled water under 
conditions of multiple turnovers.  If C1 of the p-nitrophenyl group is attacked by 
water/hydroxide then the isolated p-nitrophenolate will have a nominal molecular mass 
of 140, rather than 138.  Alternatively, if nucleophilic attack occurs at the phosphorus 
center, then the diethyl phosphate product will have a nominal mass of 155, rather than 
153.  As expected, when the hydrolysis reaction was conducted in unlabeled water the p-
nitrophenolate was isolated with an m/z of 138 and diethyl phosphate at an m/z of 153 
(Figure 7a).  However, when the hydrolysis reaction was conducted under multiple 
turnover conditions in ∼60% 18O-labeled water, the p-nitrophenolate was produced with 
an m/z of 138, whereas the diethyl phosphate was isolated as a mixture of species 
with m/z values of 153 and 155 (Figure 7b).  These results eliminate the mechanism 
depicted in Scheme 5b.  Therefore, the reaction catalyzed by Sb-PTE occurs via the 
direct attack of a nucleophile at the phosphorus center of the substrate.  
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Scheme 18: Potential chemical mechanisms for Sb-PTE 
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The mechanism depicted in Scheme 5d can be interrogated in two ways.  If the 
reaction is conducted in 18O-labeled water under single turnover conditions, then the 
recovered diethyl phosphate will not contain an 18O-label.  When we utilized a 3-fold 
molar excess of Sb-PTE to hydrolyze paraoxon in ∼60% 18O-labeled water, the isotopic 
content of the recovered diethyl phosphate was essentially the same as the solvent 
(Figure 7c).  The utilization of a side chain nucleophile from either glutamate or 
aspartate was also probed by measurement of 18O-incorporation into the protein when 
hydrolysis of paraoxon was conducted in >95% 18O-labeled water.  The net peptide 
coverage was 87% and no peptide was identified that had an M+2 or M+4 peak that 
differed significantly from that of the unlabeled control experiment.  These results are 
inconsistent with the mechanism depicted in Scheme 5d.  Stereochemical analysis of the 
products from the hydrolysis of (RP)-O-methyl O-cyclohexyl O-(p-nitrophenyl), a chiral 
thiophosphate, showed an inversion of stereochemistry at the phosphorus center 
indicating a direct attack by the activated water/hydroxide rather than forming a covalent 
intermediate (Scheme 19). The results from O18 labeling mass spectrometry and NMR 
based stereochemical analysis are consistent with the mechanism depicted 
in Scheme 18a.  
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Scheme 19: Hydrolysis of (RP)-O-methyl O-cyclohexyl O-(p-nitrophenyl) thiophosphate 
(1) to (SP)-O-methyl O-cyclohexyl thiophosphate (2) by Pd-PTE 
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3.4.4 Potential applications 
There is mounting concern about the environmental impact of the use of 
organophosphorus flame retardants in plastics and foam materials as well as concerns 
about organophosphorus solvents used industrially.  Many of these compounds are 
known or suspected carcinogens and are being produced at rates of millions of tons per 
year.  Aviation Syndrome has been directly linked to the use of tricresol phosphate (9) in 
jet fuel and lubricants (138).  Unlike insecticides, these compounds are intended to 
function under the harsh conditions of combustion and consequently are very stable.  
Typical phosphotriester enzymes have no activity against these compounds because of 
the lack of a sufficiently labile leaving group.  Sb-PTE may prove to be useful for the 
environmental remediation of these compounds because of its unique ability to 
hydrolyze phosphotriesters without an activated leaving group.  However, the structural 
and biochemical basis for the ability of Sb-PTE to hydrolyze the substrate with 
unactivated leaving group is still a mystery.  Deeper understanding on this problem will 
help to optimize the catalytic efficiency of Sb-PTE for more stable fire retardants like 
tributyl phosphotriesters by direct evolution.   
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CHAPTER IV  
 
SUMMARY AND CONCLUSION 
 
4.1   Structural Characterization of C-P Lyase Multi-Protein Complex 
 
In this study, structural models of C-P lyase multi-protein complex, PhnG-I, 
PhnG-H-I-J and PhnG-H-I-J-K were constructed by the integration of various chemical 
and physical methods including mass spectrometry, protein N-terminal sequencing, 
analytical ultra-centrifugation and cryo-electron microscopy.  Using mass spectrometry 
and protein N-terminal sequencing, the stoichiometry of protein complexes PhnG-I, 
PhnG-H-I-J and PhnG-H-I-J-K are determined as PhnG2I2, PhnG2H2I2J2 and 
PhnG2H2I2J2K, respectively.  Analytical ultra-centrifugation results indicated that there 
are no further dimerization or oligomerization in solution for these complexes.  These 
structural models also revealed the interactions between different subunits of these three 
protein complexes.  Using cryo-electron microscopy, we have solved high resolution 
(7.8 Å) structural models of the PhnG2H2I2J2 and PhnG2H2I2J2K complexes.  
In the structural models of PhnG2H2I2J2 and PhnG2H2I2J2K, PhnG2I2 works as a 
central hub where two copies of PhnJ are attached to the PhnI dimer.  PhnH is further 
attached those two copies of PhnJ.  The interactions between these subunits were 
identified and used to create an interaction map for the complex.  This map allowed for 
identification of the amino acids involved in the interface of different subunits.  In the 
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structural model of PhnG2H2I2J2K complex, one copy of PhnK associates with the 
complex by interacting with the PhnJ subunit to form a five subunit complex. This 
interaction is shown to be a helix-turn-helix motif within the helical domain of PhnK, 
which binds to α helix 6 and chock loop of PhnJ.  There are two copies of PhnJ 
associated with the complex in a symmetrical fashion, which results in two identical 
PhnK binding sites on PhnG2H2I2J2 complex.  However, only one copy of PhnK was 
observed to be associated with the complex by cyro-electron microscopy.  Further 
docking experiments revealed that the binding of the second copy of PhnK is hindered 
by considerable spacial collision with the other copy of PhnK, which explains that only 
one copy of PhnK is able to bind to the complex despite two identical binding sites.  
Furthermore, the binding of PhnK yields to a more exposed Gly-32 residue from. Gly-32 
is proposed to be a critical residue in the radical transfer chain under during the 
hydrolysis of C-P bond.  Such rearrangement around the active site may facilitate the 
delivery of the substrate or release of the reaction product.       
Recently, a crystal structure of PhnG2H2I2J2 complex was published. It revealed 
an intertwined network of subunits PhnG, PhnH, PhnI, and PhnJ with self-homologies. 
However, the binding of PhnK to the core complex remains unclear. While our 
interaction map and cryo-electron microscopy models were independently determined 
and not biased by the recently determined crystal structure of PhnG2H2I2J2, the crystal 
structure of PhnG2H2I2J2 is consistent with our results.  All identified interactions within 
the complex were observed in the crystal structure.  In addition, the crystal structure fits 
well into the cryo-EM density map of the core complex PhnG2H2I2J2 with matching 
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secondary structures.  Compared with the crystal structure, our models provide a more 
detailed view of the association of PhnK.  This structural information provides a basis 
for further deciphering of the reaction mechanism of the C-P lyase.   
 
4.2   Mechanistic Characterization of Sb-PTE 
 
Novel phosphotriesterase-like enzyme from Sphingobium sp. strain TCM1 (Sb-
PTE) has recently been reported to hydrolyze organophosphates that are not substrates 
for other phosphotriesterases, such as Pd-PTE or OpdA.  Sb-PTE may prove to be useful 
for the environmental remediation of these compounds because of its unique ability to 
hydrolyze phosphotriesters without an activated leaving group.  When this study was 
initiated, very little was known about these enzymes aside from their amino acid 
sequence and their dependence on the addition of divalent metal ions for catalytic 
activity.  Sb-PTE was expressed and purified in our lab by Dr. Daofeng Xiang.  She also 
determined the substrate profile, kinetic parameters and optimal metal of Sb-PTE 
enzyme.  
 The inhibitor 1-butynyl dibutylphosphate proved to be an incredibly potent 
inhibitor of Sb-PTE.  Full inhibition was observed with approximately 2 equiv of 
inhibitor.  The loss of catalytic activity is most likely due to the modification of one or 
more residues in the active site.  MS/MS analysis identified two serine residues (Ser-458 
and Ser-474) and two tyrosine residues (Tyr-219 and Tyr-456) as being labeled.  In the 
X-ray structure of Sb-PTE that was published later, two identified residues (Ser-474 and 
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Tyr-219) are located adjacent to the active site.  Two other residues (Tyr-456 and Ser-
458) are located in a short hydrophobic loop that is extended into the active site of the 
other subunit, precluding phosphotriester binding to the active site.  The observed 
modification of theses residues revealed the location of the active site and suggested that 
Sb-PTE may function as a dimer in solution.  We also characterized the chemical 
mechanism of Sb-PTE by O18 labeling mass spectrometry and NMR based 
stereochemical analysis.  After ruling out the possibility of a covalent reaction 
intermediate mechanism and mechanisms containing nucleophilic attack on the leaving 
group, Sb-PTE was determined to catalyze the hydrolysis of phosphotriesters by the 
direct nucleophilic attack of an activated water/hydroxide on the phosphorus center. This 
mechanism is quite similar with Pd-PTE despite the dramatic difference in protein fold.  
Currently, the crystal structure and the chemical mechanism of Sb-PTE are 
available.  However, the structural and biochemical basis for the ability of Sb-PTE to 
hydrolyze the substrate with unactivated leaving group is still a mystery.  Deeper 
understanding of this problem will allow for the optimization of the catalytic efficiency 
of Sb-PTE for degradation of more stable fire retardants like tributyl phosphotriesters by 
direct evolution.   
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